hg_229799.1

Basic information about the TSS

---

TSS ID: hg_229799.1 Species: human Chr: chr5		Start: 181242287 End: 181242301 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000507756.5 Distance: 42 GeneID: 10399 HGNC/MGI_ID: HGNC:4399 UniProt_ID: H0Y8W2

Gene_name: receptor for activated C kinase 1 Gene_symbol: RACK1 Gene_synonyms: Gnb2-rs1 H12.3 Gene_source: HGNC:4399

TATA-Box annotation

---

Distance to TSS:	-405
Nearest PromoterID:	NR_002592
Entrez ID:	619571
Nearest Unigene:
Nearest Refseq:	NR_002592
Nearest Ensembl:	ENSG00000272296
Gene Name:	receptor for activated C kinase 1
Gene Alias:	U96A
Gene Description:	small nucleolar RNA, C/D box 96A
Gene Type:	snoRNA
CpG%:	0.02
GC%:	0.507463
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RACK1 p2@RACK1 p3@RACK1 p4@RACK1 p5@RACK1 p6@RACK1 p7@RACK1 p8@RACK1 p9@RACK1 p10@RACK1
Sample		p1@RACK1	p2@RACK1	p3@RACK1	p4@RACK1	p5@RACK1	p6@RACK1	p7@RACK1	p8@RACK1	p9@RACK1	p10@RACK1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	3653.34	203.18	10.13	8.77	4.29	6.82	5.26	1.75	3.90	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	3706.88	221.34	9.71	8.30	4.65	6.27	4.25	2.43	3.03	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	3919.23	235.15	11.57	8.10	2.70	7.14	5.59	1.74	2.31	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	3592.48	208.33	11.85	7.28	4.16	4.99	1.87	1.66	1.87	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	3578.76	213.27	9.22	6.52	3.60	5.17	4.72	1.57	2.47	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	3709.92	228.50	9.50	5.23	3.10	2.71	2.91	1.55	3.10	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	4121.92	288.04	12.42	9.59	4.14	9.80	4.36	2.61	2.61	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3852.75	252.39	15.50	9.20	5.57	8.48	6.06	1.70	5.09	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	3810.57	243.42	8.98	7.48	5.98	5.13	5.98	1.28	2.14	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4146.07	235.91	9.27	6.38	4.64	4.64	5.22	2.32	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	3934.82	231.22	8.08	4.04	1.62	7.68	3.23	0.40	2.02	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	3459.36	181.73	6.10	10.98	6.10	4.47	3.66	0.00	1.63	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	3348.62	4.67	9.99	5.00	7.74	5.32	5.32	3.22	1.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	3048.80	7.37	11.43	8.57	7.67	5.41	5.26	1.80	2.26	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	2746.39	4.61	6.37	4.61	7.25	2.63	3.07	2.20	2.42	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	3012.10	6.54	13.58	10.31	9.31	6.54	5.28	4.28	2.01	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	2984.75	6.55	8.74	5.02	6.33	3.28	2.40	2.84	1.31	2.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	2634.25	7.17	12.23	13.50	11.81	5.06	4.22	2.11	3.37	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2558.61	6.40	15.46	8.00	3.20	3.20	4.27	2.13	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	3498.37	6.32	11.13	7.37	7.97	5.42	5.12	3.91	2.56	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	3051.94	6.42	12.56	7.75	8.55	5.35	5.48	5.61	2.81	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	3180.93	6.39	10.70	6.56	6.73	4.14	5.52	3.11	2.42	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	2878.81	7.24	11.37	5.82	7.76	5.04	5.17	2.71	1.55	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	3013.20	7.04	11.41	8.98	10.43	7.28	4.61	2.18	2.67	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	3054.86	5.42	11.35	5.16	5.68	3.61	3.10	2.32	2.84	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	2742.58	6.01	12.66	7.28	5.70	2.22	3.48	2.53	2.22	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	2907.19	8.24	17.03	7.69	5.49	6.59	4.40	0.55	4.40	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	3455.43	9.19	12.02	7.07	8.96	4.72	4.48	3.06	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	2919.70	8.08	10.34	7.11	5.98	5.81	5.65	3.39	1.62	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	3115.68	8.69	11.76	7.24	8.69	5.79	3.80	2.35	1.81	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	2988.80	10.89	15.49	6.70	9.42	7.12	5.86	2.72	3.35	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	2911.58	7.82	11.72	3.91	5.67	4.69	5.47	2.74	1.37	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	2763.64	9.71	11.61	4.01	9.29	6.33	4.22	2.95	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	3426.62	12.37	18.14	7.09	8.08	7.09	7.75	3.30	3.96	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	3434.07	9.54	14.02	6.36	10.28	5.98	6.17	4.67	1.87	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	3325.81	8.24	10.16	8.81	9.20	5.75	4.41	2.87	1.72	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	3438.29	8.38	10.22	6.54	6.74	3.68	6.74	3.88	2.66	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	3191.35	9.67	13.30	7.46	9.87	7.46	6.25	3.02	3.22	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	3228.00	12.15	15.67	6.75	12.69	4.86	3.78	2.97	2.97	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	2732.87	6.24	9.36	6.48	6.96	4.56	4.32	1.20	3.36	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2732.07	5.88	7.53	6.82	4.23	3.06	2.82	2.12	2.12	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	3089.06	10.98	15.08	4.83	8.93	6.88	4.98	3.37	1.90	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	3578.02	11.81	11.18	6.12	6.96	5.06	4.22	4.01	1.90	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3353.71	7.69	11.19	6.99	7.17	4.55	5.59	3.15	1.75	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	3376.20	8.63	13.05	5.42	6.83	3.01	5.02	3.61	2.61	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	3104.90	9.77	10.93	14.19	14.42	7.68	9.07	4.65	3.02	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	3525.18	8.40	11.28	3.60	6.00	4.08	5.76	2.40	2.16	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	3126.25	8.05	13.71	6.56	6.86	6.26	2.09	2.09	1.49	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	3357.46	7.18	9.81	6.46	7.42	2.87	3.83	2.63	2.15	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	3348.18	9.91	12.33	4.25	5.05	4.65	3.64	2.02	1.21	2.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	3155.47	9.63	13.73	7.99	12.91	12.71	10.04	10.86	4.51	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	3479.94	9.78	12.23	9.34	10.23	6.23	7.78	7.12	4.45	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1063.41	13.99	27.98	27.98	13.99	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	3193.37	9.94	8.52	9.94	9.23	8.87	6.74	4.26	4.26	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	3321.46	11.60	10.27	7.29	9.28	10.60	6.30	4.31	6.96	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	2846.51	14.26	13.42	10.91	19.30	14.26	16.78	6.71	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	3133.87	15.61	14.70	8.27	15.15	11.48	8.27	10.56	3.67	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4339.81	13.29	9.72	11.02	11.34	11.99	14.58	6.16	5.19	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	3522.27	8.35	8.35	8.03	6.42	6.42	2.89	4.18	4.18	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	3903.36	9.43	14.14	8.49	11.94	13.83	12.57	11.00	7.23	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3108.58	18.33	7.76	4.94	4.94	5.64	5.64	4.23	1.41	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	2813.47	15.70	11.78	11.22	15.14	7.29	10.09	2.24	3.36	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	2602.59	14.33	11.94	13.53	4.78	4.78	8.76	5.57	2.39	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	3065.38	11.89	8.83	6.12	6.80	10.19	5.44	4.08	2.38	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4808.83	18.20	8.77	15.27	10.40	7.80	6.50	5.20	2.60	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3164.29	18.81	8.52	13.13	9.94	5.68	9.23	5.68	4.26	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	840.52	0.00	16.16	16.16	0.00	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	797.65	7.90	0.00	15.79	0.00	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	2335.20	16.09	7.80	8.78	8.29	5.36	5.36	3.41	4.39	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	2307.79	17.36	5.45	11.41	8.93	7.93	7.44	3.47	2.48	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2322.58	15.01	3.28	5.16	5.16	5.63	4.22	2.35	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	2698.86	7.62	2.98	5.96	6.95	5.63	4.64	3.64	0.66	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	3120.02	10.52	6.81	10.52	7.73	8.66	6.81	3.09	2.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	2073.56	6.42	3.06	4.89	5.20	3.67	7.34	1.83	2.14	0.61
Adipocyte - breast, donor1	11376-118A8	1095.22	9.50	1.11	1.58	2.53	1.11	0.79	0.32	0.16	1.11
Adipocyte - breast, donor2	11327-117E4	1033.63	11.23	3.37	3.37	7.06	4.65	3.37	2.25	1.44	0.64
Adipocyte - omental, donor1	11473-119C6	1014.51	10.69	1.91	1.78	1.65	0.89	0.89	0.64	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	930.63	6.73	4.48	1.49	0.00	2.24	0.75	2.24	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	1124.99	6.70	5.02	3.01	1.67	2.68	2.34	1.00	1.34	0.33
Adipocyte - perirenal, donor1	11476-119C9	1095.43	7.66	5.10	1.28	3.83	1.91	1.91	1.28	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	1715.23	9.90	9.90	3.30	2.20	4.40	1.10	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	1924.37	40.19	4.97	1.81	2.26	0.45	0.00	0.45	0.00	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	2960.97	8.86	7.65	4.52	4.34	5.91	4.00	0.87	2.09	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	1306.23	4.50	2.35	1.76	1.37	0.78	0.39	0.39	0.98	2.74
Adipocyte differentiation, day04, donor2	13022-139D7	1030.29	3.86	2.06	3.86	2.32	2.32	0.26	0.00	1.03	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	1021.14	6.41	1.67	3.35	1.39	2.51	0.56	0.00	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	909.93	7.64	0.59	1.76	0.59	0.00	0.59	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	1076.36	7.72	0.88	1.29	1.21	0.40	0.40	0.32	0.32	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	987.31	2.90	1.94	2.90	0.97	0.97	0.32	0.65	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	950.67	5.87	5.87	2.67	1.07	3.20	1.60	2.67	2.13	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	746.74	3.90	1.67	1.67	1.67	0.00	0.00	0.56	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	918.71	9.98	0.83	1.66	0.83	1.66	0.83	0.42	0.83	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	758.02	2.01	2.01	1.51	1.00	1.51	0.50	0.75	0.25	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	794.88	4.25	1.96	2.29	0.65	0.98	1.64	0.33	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	507.55	9.13	0.61	0.30	0.61	0.61	0.00	0.61	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	1857.26	48.18	2.21	2.21	1.33	1.10	0.44	0.44	0.44	3.54
Alveolar Epithelial Cells, donor2	11590-120G6	1963.24	46.26	5.74	3.94	4.30	6.81	2.51	2.51	1.08	6.45
Alveolar Epithelial Cells, donor3	11671-122G6	2170.80	4.79	0.00	3.59	3.59	5.99	1.20	0.00	0.00	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	2176.50	14.75	1.44	2.34	0.72	0.18	0.90	0.18	0.90	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	2592.24	6.69	6.69	3.35	1.67	0.00	0.00	5.02	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	2281.49	8.83	2.67	4.93	3.29	2.67	2.05	1.23	0.82	1.44
Anulus Pulposus Cell, donor1	11248-116E6	2565.66	5.49	2.75	2.98	1.72	2.40	0.80	0.80	1.26	0.46
Anulus Pulposus Cell, donor2	11463-119B5	2002.12	3.92	3.43	4.41	3.18	4.90	3.43	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	1313.74	19.32	6.29	6.74	4.49	8.54	5.39	1.80	3.15	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	1463.05	21.27	4.78	4.34	3.04	3.91	3.04	2.17	1.74	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	1996.85	29.96	10.70	17.12	12.84	8.56	0.00	10.70	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	1308.68	15.25	5.38	4.48	4.18	5.98	5.38	2.99	3.59	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	1453.09	18.97	12.65	10.12	8.85	8.85	8.85	5.06	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1845.56	17.82	2.64	6.60	7.92	8.58	3.96	1.32	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	1278.75	21.12	4.55	6.17	4.55	6.50	4.55	2.27	3.25	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	1433.51	18.45	3.40	5.34	2.91	4.37	3.40	2.43	1.94	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1851.12	24.94	5.34	10.69	10.69	5.34	10.69	2.38	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	1353.26	18.46	6.40	6.78	6.78	5.65	7.91	1.88	2.64	2.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	1301.13	18.87	7.98	4.35	2.90	3.63	2.90	0.73	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1573.49	18.81	8.78	17.55	11.28	6.27	3.76	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	1825.44	31.46	1.65	2.64	1.32	1.48	0.99	0.49	1.48	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	1053.63	15.01	4.09	4.09	1.36	9.55	0.00	1.36	2.73	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	1692.63	26.24	2.87	5.58	1.96	1.96	1.66	0.15	1.06	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1298.75	12.32	4.82	5.89	3.21	2.68	3.75	0.54	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	1427.98	17.57	5.48	6.42	2.83	5.10	3.40	1.70	1.89	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	1621.89	20.31	6.41	7.22	3.74	5.61	4.54	2.67	2.14	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	1030.08	13.66	6.83	5.85	3.90	7.80	3.90	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	1413.45	15.76	3.81	4.15	3.32	4.31	2.49	1.00	1.49	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	1789.08	21.61	10.81	12.01	10.81	13.21	9.61	3.60	6.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	1203.65	14.16	7.08	0.00	7.08	3.54	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	1472.07	21.78	2.74	2.40	3.43	3.09	2.57	1.54	1.72	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	1669.59	12.58	4.19	25.17	4.19	8.39	0.00	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	1422.78	15.53	6.80	4.37	3.88	9.22	2.91	0.97	2.43	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	1627.84	20.11	4.17	1.90	4.93	4.17	3.04	0.00	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1909.11	26.65	8.48	4.85	7.27	9.69	3.63	3.63	4.85	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	1338.44	18.81	10.83	4.56	6.84	5.13	5.13	0.57	3.99	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	1555.21	19.88	4.92	3.42	2.99	5.56	3.42	0.86	0.86	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	1611.25	16.78	5.42	4.90	6.19	3.87	2.58	2.58	1.81	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1449.85	18.77	5.16	5.16	4.69	6.57	4.69	0.94	0.94	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	1561.44	19.61	4.50	2.25	2.89	3.22	4.50	0.96	2.25	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	1867.82	19.26	2.85	6.42	7.13	2.14	2.85	2.85	0.71	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1267.00	11.70	4.68	4.68	2.34	2.92	2.92	1.75	2.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	1621.88	21.98	6.32	1.51	3.31	5.42	5.12	1.20	0.60	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	1916.23	21.38	4.75	17.82	8.32	7.13	9.50	7.13	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	1525.17	16.78	6.10	7.63	7.12	7.12	7.63	3.05	2.03	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	1596.64	20.88	5.35	5.86	3.06	6.62	7.13	1.78	2.04	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1624.00	24.78	5.08	15.25	7.62	3.18	4.45	2.54	2.54	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	1339.48	21.15	1.73	3.02	4.32	7.77	3.02	4.32	1.73	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1456.82	22.02	2.75	4.87	3.60	4.45	2.75	1.06	2.54	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1553.43	25.81	4.93	5.22	4.64	8.12	3.19	1.45	1.16	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1212.10	17.95	7.56	2.83	4.72	2.83	2.83	1.89	1.89	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	1504.87	22.89	3.90	5.42	3.22	2.88	2.03	1.19	1.02	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	1707.16	30.11	6.95	11.58	9.27	9.27	0.00	2.32	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	1056.29	14.79	2.11	2.11	8.45	4.23	2.11	2.11	2.11	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	1544.84	16.08	3.22	5.79	3.65	5.15	3.22	1.50	1.29	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	1798.37	25.27	7.82	6.62	7.22	4.81	4.81	1.80	4.21	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	1305.60	12.39	8.02	3.64	8.75	2.19	2.92	0.73	3.64	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	1612.62	21.84	3.91	4.37	3.45	3.91	5.29	1.61	2.07	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	1820.91	20.40	12.75	12.75	7.65	10.20	2.55	2.55	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1769.19	34.58	2.03	5.34	3.05	1.78	1.27	1.02	1.53	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	1645.12	22.30	4.13	3.72	3.92	5.57	2.48	1.03	1.86	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	1623.94	20.20	6.73	3.37	6.73	4.59	4.28	1.84	1.53	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	1306.41	18.16	8.60	7.65	3.35	10.04	2.39	0.96	3.82	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	1607.39	17.07	3.77	3.99	2.66	3.10	4.43	2.66	1.55	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1779.08	16.78	10.68	18.31	9.15	7.63	6.10	3.05	9.15	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1363.12	14.95	7.20	5.54	1.66	2.22	2.22	0.55	2.22	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	1484.97	18.54	5.30	5.30	4.24	5.03	2.38	1.32	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1707.11	18.54	5.45	7.63	5.09	6.18	3.27	3.63	2.18	0.36
Astrocyte - cerebellum, donor1	11500-119F6	2519.70	19.65	2.33	3.19	1.23	2.33	0.98	0.86	0.25	2.33
Astrocyte - cerebellum, donor2	11580-120F5	2473.43	8.73	4.28	2.23	3.59	3.08	3.25	1.71	2.23	4.96
Astrocyte - cerebellum, donor3	11661-122F5	3158.17	9.02	3.57	3.99	3.36	2.94	1.26	1.26	2.52	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	2517.48	12.55	2.44	5.93	3.49	0.70	0.35	0.70	1.74	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	2343.13	27.18	4.21	6.47	5.34	7.28	4.53	3.24	2.10	2.59
Astrocyte - cerebral cortex, donor3	11392-118C6	2258.44	9.99	3.43	5.52	2.98	5.07	2.98	1.94	1.94	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	2607.60	11.58	2.64	3.67	4.13	6.42	5.05	2.98	2.06	2.18
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	2530.44	20.17	1.75	2.00	2.13	3.76	2.38	1.25	0.63	4.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2469.73	16.50	2.96	1.48	2.39	3.07	1.48	0.68	1.37	2.50
Basophils, donor1	12241-129G9	1758.55	1.57	0.78	2.35	0.52	0.26	0.26	0.26	0.26	0.00
Basophils, donor2	12242-129H1	2153.59	3.97	2.16	3.61	1.80	1.44	0.36	0.00	0.72	0.00
Basophils, donor3	12243-129H2	1729.28	2.65	1.32	1.91	1.03	0.88	0.73	0.73	0.88	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	2508.11	20.48	3.02	1.72	1.29	1.29	1.08	0.65	0.43	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	2059.16	14.17	2.29	4.11	3.66	2.74	1.37	0.00	1.83	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	4296.97	7.17	7.17	35.87	14.35	7.17	21.52	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	1880.45	75.95	4.39	8.16	6.28	5.65	5.65	3.14	1.26	3.77
Bronchial Epithelial Cell, donor5	11457-119A8	2147.92	56.77	8.32	3.54	4.16	4.99	3.54	1.87	2.70	4.37
Bronchial Epithelial Cell, donor6	11461-119B3	2583.63	43.76	8.29	10.59	9.90	7.83	6.45	2.76	3.45	2.53
Bronchial Epithelial Cell, donor7	11769-123I5	2176.98	7.74	5.22	5.04	3.06	6.12	3.78	3.24	2.52	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	3628.68	34.52	1.55	2.16	2.16	1.34	0.31	1.03	0.62	2.78
Burkitt's lymphoma cell line:RAJI	10476-106I8	3680.58	38.20	1.40	3.26	1.86	1.16	3.73	3.26	0.00	5.12
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	5998.66	19.83	2.56	6.72	3.84	3.84	2.56	1.60	0.96	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	8366.63	10.34	0.00	0.00	10.34	10.34	10.34	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	1539.63	3.38	0.56	2.25	1.69	0.56	0.00	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	1400.54	2.60	2.41	2.04	3.53	3.53	2.60	1.67	1.11	0.56
CD14+ Monocytes, donor3	11381-118B4	1474.41	2.41	1.76	3.51	2.41	2.20	1.76	0.88	1.76	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1159.63	0.28	2.26	1.13	0.57	0.00	1.13	0.57	0.57	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1177.41	0.38	1.52	4.17	1.52	0.76	1.14	0.76	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1100.29	1.97	1.31	0.99	0.99	0.66	0.66	0.00	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	1557.23	2.89	3.90	5.06	8.38	3.47	3.32	4.77	1.30	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	1453.50	3.92	3.62	5.13	6.03	3.32	2.11	1.81	0.91	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	1388.19	3.32	2.13	5.45	4.97	2.37	1.90	1.66	1.18	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1319.60	3.52	3.18	6.53	5.19	2.85	1.51	1.34	1.34	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1258.61	2.21	2.76	3.86	4.69	1.66	1.93	1.93	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1255.76	3.97	1.74	4.96	4.21	0.99	1.49	1.24	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1271.73	1.57	3.33	5.09	4.90	3.92	2.94	2.15	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1519.47	2.49	2.31	5.52	5.52	3.74	1.60	2.49	1.07	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1785.00	3.48	2.83	6.53	4.79	2.83	2.39	1.09	2.39	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1443.63	2.81	4.21	4.68	3.28	2.11	2.34	2.81	1.40	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1630.02	5.28	4.22	5.28	8.45	5.28	2.11	1.58	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1710.63	4.44	3.33	5.55	2.22	2.22	4.44	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1470.83	2.38	2.83	7.59	7.14	3.42	3.27	2.38	1.04	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1316.02	4.79	1.80	4.39	5.19	3.59	2.59	1.40	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1627.70	4.58	3.75	6.66	5.41	3.33	1.46	1.04	0.42	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1662.58	4.80	3.89	7.55	8.47	4.12	2.75	2.97	2.52	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1516.02	4.52	4.30	4.07	2.26	2.71	0.45	0.90	1.13	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1282.76	6.11	4.36	4.36	5.24	3.06	0.87	1.75	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1425.65	2.42	4.03	3.50	5.92	2.69	1.61	1.34	2.42	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1640.80	3.49	2.27	8.03	8.03	3.31	2.62	2.79	0.87	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1522.53	2.52	3.37	5.47	4.21	2.10	2.52	1.26	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1382.24	2.76	2.57	2.39	4.96	3.86	1.65	2.20	1.10	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1242.44	4.23	1.76	2.11	1.76	1.06	1.41	0.35	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1158.24	4.83	0.88	4.83	4.83	3.07	0.88	0.88	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1220.44	2.62	3.31	3.31	5.41	3.84	3.31	2.27	1.57	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1425.38	2.97	3.72	5.20	4.46	3.35	1.86	2.23	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1738.84	2.80	2.37	4.96	5.17	2.16	1.72	1.51	1.51	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1432.80	1.64	1.64	5.73	5.32	3.69	2.05	2.05	1.64	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1463.81	3.25	1.62	3.48	2.55	1.85	0.23	0.46	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1576.62	5.57	1.16	5.57	3.02	2.09	2.32	2.32	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	1964.51	1.53	3.05	5.89	6.76	5.67	1.96	1.74	1.96	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	2026.51	4.39	2.08	6.01	6.01	3.00	1.62	0.92	1.62	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	1902.10	2.82	1.30	3.90	1.08	1.30	1.30	1.52	0.65	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	2500.12	3.89	2.96	3.58	3.27	3.58	1.87	1.56	1.40	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	2139.04	3.32	2.62	3.84	3.14	1.57	2.27	1.05	1.75	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	1548.97	1.11	0.45	1.11	0.22	0.67	0.67	0.67	0.45	1.56
CD14-CD16+ Monocytes, donor1	11790-124B8	2168.73	3.06	1.53	5.61	1.28	3.06	1.02	0.77	1.28	1.53
CD14-CD16+ Monocytes, donor2	11800-124C9	1927.56	3.73	4.39	4.39	6.15	3.51	2.85	1.76	1.76	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	1733.85	1.89	1.89	2.11	0.84	1.05	0.42	0.42	0.63	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	5426.27	8.13	4.06	10.16	10.16	2.03	2.03	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4930.94	4.07	6.10	8.81	4.07	4.75	4.07	0.68	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	5420.32	4.14	7.25	12.43	3.11	5.18	1.04	5.18	3.11	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4938.06	4.26	1.07	9.59	3.20	3.73	0.53	0.53	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5756.83	3.22	9.65	16.62	4.29	5.90	3.22	3.22	2.14	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4796.34	5.62	7.02	8.42	6.32	2.11	2.11	0.00	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	5412.83	2.35	7.84	7.84	7.06	4.71	5.49	1.57	2.35	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	5846.60	0.00	3.95	5.27	3.95	3.95	3.95	0.00	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	3979.64	4.93	3.29	9.86	9.86	5.75	4.11	4.11	5.75	0.00
CD19+ B Cells, donor2	11624-122B4	3867.25	3.63	7.25	6.53	2.18	5.80	4.35	2.18	2.18	1.45
CD19+ B Cells, donor3	11705-123B4	3470.68	3.03	5.55	6.06	4.04	6.56	1.51	3.03	4.04	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1366.52	6.87	2.02	0.40	0.00	0.00	1.62	0.00	0.00	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1178.10	5.99	0.40	0.00	0.40	0.80	0.00	0.00	1.20	1.20
CD34+ Progenitors, donor1	11545-120B6	4180.86	4.02	5.02	14.06	5.02	10.04	2.01	2.01	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	3657.37	4.49	5.62	5.62	3.37	2.81	0.56	1.69	1.12	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	4892.33	14.65	3.38	4.88	4.51	1.88	1.88	1.50	1.13	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	5559.52	24.80	5.41	4.28	4.28	3.83	3.38	1.13	1.80	2.03
CD4+ T Cells, donor1	11225-116C1	3574.14	6.78	1.07	3.93	2.86	1.07	0.36	1.07	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	4309.20	4.29	7.96	14.70	12.25	14.08	15.31	5.51	9.80	0.61
CD4+ T Cells, donor3	11382-118B5	3623.02	4.27	5.79	13.11	5.49	7.62	5.79	3.05	3.35	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2705.00	6.13	5.10	5.87	5.87	2.55	3.06	1.28	1.02	2.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	3764.92	4.04	3.82	4.27	2.70	2.02	2.70	0.90	1.12	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	3279.93	2.59	2.59	4.02	3.16	2.87	2.30	1.44	1.15	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	6300.20	6.16	5.69	11.38	9.01	7.59	7.11	2.37	5.69	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	7764.87	9.13	12.64	15.45	11.24	5.62	4.92	0.00	4.92	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6480.38	9.89	6.59	19.78	19.78	6.59	3.30	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2202.99	8.09	4.19	6.07	6.07	2.17	2.75	1.88	1.01	1.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	2365.53	4.58	5.08	5.08	5.76	6.27	4.41	3.05	1.69	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1832.26	4.19	2.90	5.00	4.03	3.87	2.10	1.77	2.26	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	3609.25	4.48	7.62	11.66	10.76	6.28	2.24	1.34	2.69	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	4291.19	6.29	6.99	7.69	5.94	6.29	4.89	5.94	1.40	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	3048.63	2.64	2.64	3.52	4.84	1.32	1.76	1.76	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2776.08	3.79	2.11	3.79	3.79	2.11	3.37	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	2718.25	5.19	3.74	9.56	7.06	1.87	4.16	2.70	2.70	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2691.07	3.68	3.01	7.35	6.68	6.68	4.01	3.34	1.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	5271.99	5.71	6.53	12.51	9.25	5.98	5.44	2.45	1.90	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	5751.27	6.43	5.90	13.93	7.50	8.04	3.75	5.90	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5182.43	12.55	19.73	12.55	12.55	7.17	5.38	5.38	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	2580.23	12.79	2.97	5.38	3.15	2.78	1.67	0.56	1.48	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	2420.05	10.18	1.95	2.17	3.90	1.95	1.95	1.08	1.08	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	2203.65	5.46	2.31	3.57	3.57	3.99	2.31	1.26	0.21	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	4480.16	7.58	5.56	8.09	6.07	5.56	4.55	2.53	2.02	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	4914.80	7.80	4.77	10.83	3.03	8.23	3.47	1.30	2.60	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3381.49	3.92	3.05	9.59	5.67	4.79	1.74	4.36	2.18	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	5424.26	4.95	7.42	9.40	8.41	7.42	5.44	0.99	1.98	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	5345.24	5.54	5.54	5.54	6.46	2.77	0.92	1.85	2.77	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5506.52	16.75	6.98	13.96	6.98	9.77	5.58	2.79	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	4001.07	4.98	5.26	4.71	5.26	4.43	3.32	1.38	2.22	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	4206.00	3.44	5.64	5.40	5.15	3.68	2.45	0.74	1.23	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	5038.90	12.32	4.62	6.16	6.16	4.62	3.08	1.54	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	4635.47	5.01	2.86	7.52	6.45	6.80	4.30	4.66	1.79	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5142.47	5.54	2.77	11.08	9.69	4.15	4.15	0.00	8.31	0.00
CD8+ T Cells, donor1	11226-116C2	2687.26	6.55	1.96	3.93	3.27	1.31	1.96	0.65	2.62	0.65
CD8+ T Cells, donor2	11307-117C2	2330.68	4.88	4.13	5.26	8.26	7.88	5.26	5.26	7.13	0.00
CD8+ T Cells, donor3	11383-118B6	3678.51	6.56	4.54	8.84	7.57	4.04	4.80	3.53	4.04	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	2596.71	31.20	2.75	4.82	2.52	4.82	2.75	3.44	1.15	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	2482.22	24.44	3.35	3.59	2.88	2.40	2.16	1.68	1.68	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2621.55	29.55	6.29	5.75	4.92	4.92	4.38	1.37	1.09	3.01
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3479.45	37.53	5.10	4.80	3.30	8.11	5.40	1.50	2.40	3.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2582.45	30.48	2.64	3.36	3.36	3.12	2.40	0.96	0.96	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2720.90	26.15	5.23	2.96	2.05	3.87	2.27	0.68	1.36	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2221.95	40.63	5.00	2.39	2.39	4.13	1.74	0.43	0.65	4.35
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2394.63	47.38	3.16	5.00	4.74	3.42	3.16	1.58	3.16	3.95
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2106.65	35.88	3.75	4.92	2.11	3.99	2.58	1.41	2.11	2.58
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2106.20	43.77	4.83	6.34	3.62	3.32	1.81	0.91	1.51	3.62
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2085.53	43.58	3.49	4.36	3.49	4.94	2.91	1.16	1.45	2.91
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2394.18	44.76	4.26	2.93	3.73	3.73	1.87	0.80	1.33	2.93
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2188.75	23.20	1.75	4.38	1.31	0.88	1.31	0.00	1.31	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	2197.45	22.32	1.37	4.10	2.28	0.91	1.37	0.46	1.37	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1991.48	14.17	2.24	5.22	0.75	1.49	0.00	0.75	0.75	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2984.61	32.77	4.68	2.52	3.60	5.40	6.12	0.72	1.08	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2764.72	28.77	4.32	8.34	2.59	4.32	3.16	0.86	0.86	3.45
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2379.83	24.04	2.36	3.54	1.18	3.06	1.18	0.71	0.47	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	2523.19	36.44	4.75	4.44	3.17	2.22	0.95	0.95	1.90	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2556.47	40.60	5.23	5.84	3.08	3.08	2.15	0.92	0.92	2.77
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2261.07	35.58	2.56	1.92	3.53	1.92	1.92	0.32	1.92	4.17
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2283.70	56.22	3.44	3.44	3.82	3.82	3.06	0.76	1.53	4.59
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	2214.87	45.32	3.94	4.73	2.36	0.79	1.97	0.39	1.97	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2204.19	54.46	5.29	3.03	0.76	2.27	3.03	3.03	1.51	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	2011.41	18.47	3.21	4.01	1.61	0.80	2.41	0.80	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1995.47	18.19	0.00	2.80	0.70	2.10	2.10	0.70	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2621.58	19.03	3.01	3.01	1.00	2.00	4.01	0.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	1392.74	7.31	3.66	0.00	5.48	0.00	0.00	3.66	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	1971.42	11.86	3.95	5.93	3.46	4.94	3.46	1.98	2.47	0.00
Cardiac Myocyte, donor3	11686-122I3	2454.02	12.94	0.74	1.26	1.47	0.21	0.53	0.11	0.53	1.58
Chondrocyte - de diff, donor1	11261-116G1	1540.59	13.87	1.39	1.39	2.08	0.35	0.35	1.04	0.35	2.08
Chondrocyte - de diff, donor2	11338-117F6	1717.89	5.69	3.91	2.13	1.78	0.00	1.07	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	2035.73	5.35	4.44	3.19	2.28	3.87	3.98	1.48	1.71	0.46
Chondrocyte - re diff, donor2	11339-117F7	995.52	3.58	2.69	0.90	0.00	0.00	0.00	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	1336.96	1.62	4.45	7.28	1.62	2.02	1.21	1.21	2.43	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	2644.95	11.71	1.95	2.75	2.41	1.95	2.30	0.80	1.49	1.26
Ciliary Epithelial Cells, donor2	11323-117D9	2295.63	11.76	10.69	9.83	4.28	5.13	7.27	1.71	2.99	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	2307.49	13.36	3.10	4.78	3.27	4.25	3.36	0.97	2.12	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	1006.23	1.01	0.92	1.10	0.64	1.19	0.37	0.37	0.46	0.92
Corneal Epithelial Cells, donor1	11526-119I5	2335.15	23.49	1.32	1.76	1.32	0.88	1.10	0.00	0.44	1.76
Corneal Epithelial Cells, donor2	11606-120I4	2319.57	36.40	6.83	3.41	5.69	2.28	3.41	2.28	2.28	1.14
Corneal Epithelial Cells, donor3	11687-122I4	2409.83	42.95	3.07	4.86	3.07	4.35	4.09	2.81	1.02	4.09
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	613.83	3.63	0.66	1.49	0.83	0.17	0.83	0.17	0.83	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	608.42	5.68	0.00	0.32	0.63	0.00	0.32	0.32	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	804.01	0.00	3.45	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	622.24	2.48	0.97	0.97	1.62	1.73	1.19	0.43	1.30	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	2523.02	4.10	2.05	6.49	2.73	1.71	0.34	0.00	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3328.99	6.53	3.26	1.31	3.26	1.96	0.65	1.31	1.31	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	2418.27	3.39	3.87	3.39	2.90	1.94	0.97	0.00	1.45	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	1788.93	34.69	1.17	2.17	0.83	0.50	1.00	0.17	0.33	2.33
Endothelial Cells - Aortic, donor1	11263-116G3	1978.61	20.54	2.35	2.35	2.35	0.59	0.00	0.59	1.76	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	1722.80	23.19	1.13	1.70	1.13	1.41	0.00	0.28	0.57	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	1886.10	25.16	2.75	2.75	1.57	1.57	0.79	0.00	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	1877.88	24.14	5.53	1.16	2.04	2.04	1.16	1.16	0.87	1.45
Endothelial Cells - Artery, donor2	11341-117F9	2251.85	37.17	5.18	1.65	5.88	7.76	4.47	3.06	1.41	1.41
Endothelial Cells - Artery, donor3	11413-118E9	2196.62	37.34	2.63	3.68	4.21	3.33	2.45	1.75	1.75	2.98
Endothelial Cells - Lymphatic, donor1	11236-116D3	1731.99	7.54	2.22	3.10	1.55	0.66	0.89	1.33	0.66	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	1467.18	7.00	0.30	4.87	1.83	1.52	1.83	0.61	0.30	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	1342.14	3.95	0.56	1.41	1.41	0.56	0.28	0.56	0.56	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	1786.07	19.31	3.27	2.08	1.78	0.59	1.49	0.00	0.59	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	1523.46	38.53	3.64	1.56	1.56	0.52	1.04	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	2345.15	4.96	4.54	4.68	4.68	3.69	3.40	1.56	1.99	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	1623.69	45.61	1.20	2.40	2.40	2.40	0.80	0.00	1.20	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	1851.21	22.01	5.24	5.24	6.29	8.39	6.81	2.10	2.62	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	2052.92	23.98	1.12	3.35	1.12	2.11	1.74	0.37	0.99	1.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	1458.91	13.47	1.74	1.96	1.09	1.52	0.65	0.22	1.30	1.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	1224.82	15.02	0.98	2.44	1.95	1.10	0.73	1.10	0.85	1.59
Endothelial Cells - Vein, donor1	11267-116G7	2147.61	37.54	2.28	6.83	2.28	0.00	3.41	1.14	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	2022.16	51.69	2.10	0.70	1.40	2.10	4.19	1.40	1.40	2.79
Endothelial Cells - Vein, donor3	11416-118F3	2069.51	27.48	4.24	5.50	2.67	4.87	2.51	1.73	2.83	1.88
Eosinophils, donor1	12244-129H3	3171.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	478.58	3.30	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	449.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1916.49	23.46	2.20	2.44	0.49	0.49	0.00	0.24	0.98	1.95
Esophageal Epithelial Cells, donor2	11587-120G3	2514.92	8.32	2.08	2.08	0.00	6.24	4.16	6.24	0.00	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	3595.40	48.81	16.27	0.00	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	1312.83	6.16	4.93	3.28	3.69	1.64	1.23	2.46	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	1488.71	30.33	16.86	31.09	16.20	13.91	6.68	4.82	8.65	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2691.11	23.51	10.94	8.78	6.07	10.08	7.58	3.90	3.25	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	1722.42	33.47	3.76	3.76	2.43	1.21	1.82	1.09	1.09	2.18
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	813.64	32.48	0.68	1.23	0.41	0.27	0.41	0.14	0.55	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	1861.53	14.24	4.54	2.43	4.54	3.90	3.48	1.79	1.37	1.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	806.02	11.33	2.11	1.58	1.32	1.05	1.05	1.05	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	1693.22	13.29	2.66	3.32	2.33	3.65	3.65	1.00	1.66	1.99
Fibroblast - Cardiac, donor1	11268-116G8	1880.28	26.31	5.44	3.18	3.18	4.99	4.08	2.72	1.81	1.36
Fibroblast - Cardiac, donor2	11345-117G4	1994.16	38.66	3.79	4.55	3.03	0.76	3.79	0.76	2.27	3.03
Fibroblast - Cardiac, donor3	11417-118F4	1677.47	32.65	4.42	2.84	3.63	4.73	3.31	2.37	1.89	1.42
Fibroblast - Cardiac, donor4	11452-119A3	1401.27	8.49	1.21	2.12	1.52	0.61	0.61	0.61	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	1808.13	15.10	4.70	3.81	2.92	4.06	2.92	1.52	1.52	1.65
Fibroblast - Cardiac, donor6	11460-119B2	1547.93	17.89	3.79	4.24	2.88	4.24	3.03	1.52	1.36	2.73
Fibroblast - Choroid Plexus, donor1	11492-119E7	2222.90	10.32	1.88	3.48	1.74	1.74	1.21	0.80	0.54	1.61
Fibroblast - Choroid Plexus, donor2	11572-120E6	2292.61	2.59	6.04	3.02	1.73	3.45	0.43	0.86	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	2293.87	19.04	2.93	4.39	1.46	5.86	11.72	2.93	2.93	7.32
Fibroblast - Conjunctival, donor1	11531-120A1	2490.21	18.22	0.92	1.85	1.61	0.46	0.46	0.23	0.46	2.08
Fibroblast - Conjunctival, donor3	11692-122I9	3484.86	3.56	2.20	3.05	2.37	3.56	1.87	1.87	1.36	0.51
Fibroblast - Dermal, donor1	11269-116G9	2550.90	29.11	6.57	2.58	2.58	2.58	1.88	0.94	0.70	1.88
Fibroblast - Dermal, donor2	11346-117G5	1886.24	53.30	2.83	1.42	0.94	0.94	0.00	0.47	0.47	2.83
Fibroblast - Dermal, donor3	11418-118F5	2619.60	23.94	6.53	5.20	2.66	5.20	3.38	1.81	1.57	1.57
Fibroblast - Dermal, donor4	11450-119A1	1800.93	16.73	4.97	3.62	3.62	5.31	3.84	1.92	2.03	3.39
Fibroblast - Dermal, donor5	11454-119A5	1940.97	22.50	4.88	5.41	5.93	3.66	2.79	2.62	2.44	4.19
Fibroblast - Dermal, donor6	11458-119A9	2058.39	25.34	4.87	3.09	2.60	4.22	3.09	0.81	1.30	3.41
Fibroblast - Gingival, donor1	11237-116D4	1798.69	10.20	1.25	2.08	1.46	0.62	1.04	0.00	0.21	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	1860.98	7.07	3.41	2.36	3.67	0.52	1.05	1.57	1.05	1.05
Fibroblast - Gingival, donor2	11318-117D4	2115.39	16.34	4.88	3.69	5.01	8.30	5.67	2.50	1.58	1.58
Fibroblast - Gingival, donor3	11394-118C8	2134.56	5.03	2.32	2.32	2.13	1.93	2.42	0.68	1.06	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	1092.91	5.19	1.04	0.00	1.04	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	1377.38	4.76	4.58	4.58	3.00	4.93	1.76	2.11	2.47	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1729.05	12.32	1.09	2.49	1.40	1.09	1.09	0.78	0.47	3.74
Fibroblast - Gingival, donor6 (control)	11922-125H5	1618.00	13.66	5.41	2.70	2.84	2.03	2.16	1.35	0.54	1.76
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1212.14	7.06	1.06	0.00	0.00	0.00	0.35	0.00	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	1650.37	10.82	3.07	1.61	1.61	1.75	1.02	1.32	0.58	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1441.12	14.59	3.68	1.36	0.95	1.09	1.50	1.23	1.09	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	1509.05	17.11	2.19	1.86	2.52	2.52	1.97	1.43	0.66	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	2490.75	2.35	5.58	2.79	2.35	2.49	1.32	1.32	1.03	0.44
Fibroblast - Lung, donor1	11270-116H1	2151.85	9.52	6.80	1.36	0.00	1.36	2.72	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	1711.50	1.49	5.97	2.98	0.00	2.98	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	2492.97	11.61	7.81	5.91	5.06	4.85	5.70	1.90	2.74	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	2339.96	42.48	2.50	3.33	3.33	2.50	0.00	0.00	0.83	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	1818.22	6.99	0.00	0.00	4.20	4.20	0.00	1.40	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	1782.25	10.92	1.68	1.68	1.96	3.64	0.84	1.40	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	2415.52	24.76	1.62	1.62	0.00	1.22	0.00	0.81	0.41	2.44
Fibroblast - Mammary, donor2	11620-122A9	2783.96	11.98	0.00	19.97	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	3001.96	17.87	0.00	5.96	0.00	0.00	0.00	0.00	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	2066.60	12.41	1.16	3.69	2.33	0.58	0.58	0.19	0.58	3.30
Fibroblast - Periodontal Ligament, donor2	11319-117D5	1819.12	11.22	1.97	3.03	1.97	2.28	3.34	1.52	1.21	2.43
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1279.33	15.91	0.31	1.22	0.00	0.00	0.31	0.00	0.00	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	1211.27	6.49	1.53	2.29	1.14	1.14	0.76	0.00	0.76	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	1470.10	12.69	7.29	6.21	4.05	7.29	4.32	2.43	1.08	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	1173.08	3.83	2.20	2.32	2.78	1.86	1.74	0.46	1.04	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	1707.40	48.08	2.54	2.32	2.21	2.32	2.21	0.33	0.99	1.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	1925.43	17.27	0.41	2.24	0.81	0.61	0.81	0.00	1.02	1.83
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2447.63	13.36	1.34	4.01	3.34	2.67	2.67	0.00	1.34	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	2816.95	5.93	4.74	5.54	1.58	5.54	2.37	1.98	2.37	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	964.65	9.92	1.39	0.99	0.99	1.98	0.60	1.19	0.40	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	2142.61	6.04	1.78	1.78	1.42	0.89	0.53	0.71	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	2246.18	10.84	2.37	2.96	2.17	2.37	0.39	0.20	1.38	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1012.38	11.73	0.60	0.90	1.50	1.50	1.20	0.30	0.00	3.31
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1523.84	9.50	1.51	1.73	3.24	1.51	1.51	0.97	1.08	1.73
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	784.02	7.09	0.25	0.51	1.27	0.76	0.51	0.25	0.00	1.01
Fibroblast - skin normal, donor1	11553-120C5	1702.97	7.38	1.97	2.13	0.33	1.15	0.33	0.82	0.16	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	934.56	18.45	0.20	0.80	0.80	0.00	0.80	0.20	0.00	1.80
Fibroblast - skin normal, donor2	11561-120D4	1303.60	9.85	1.91	1.11	1.61	1.51	0.80	1.00	0.40	1.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	973.51	8.76	0.91	0.00	0.60	0.30	1.21	1.51	0.30	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	2607.41	6.96	1.91	2.65	1.74	1.24	1.91	0.50	1.16	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	2163.04	4.62	3.08	3.93	5.81	3.59	2.22	0.68	0.85	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	763.28	4.93	0.99	0.66	0.99	1.31	0.33	0.33	0.33	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1155.23	10.23	0.75	2.13	2.24	0.96	0.64	0.75	0.43	1.49
Fibroblast - skin walker warburg, donor1	11554-120C6	1561.98	16.36	1.01	1.69	0.84	1.18	0.34	0.84	0.34	2.53
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	2127.26	9.57	8.94	7.06	7.68	8.15	10.04	3.14	3.14	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1063.67	22.16	0.00	0.00	22.16	0.00	22.16	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1874.66	8.72	5.23	5.23	2.61	2.61	1.74	0.00	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1263.78	44.21	2.43	1.21	2.25	1.39	0.35	0.52	1.04	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1398.27	46.06	1.30	3.12	0.78	0.52	0.52	0.52	0.00	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	1070.85	52.89	0.51	1.53	1.28	0.77	0.00	0.51	1.28	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3457.23	108.71	20.67	13.01	6.89	14.55	3.06	6.12	1.53	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	3912.02	137.19	34.46	23.61	14.04	12.12	12.12	7.66	3.83	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4698.86	84.44	20.54	9.13	8.56	9.41	6.28	4.56	3.14	3.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	5450.34	8.00	72.80	11.86	6.62	8.55	5.24	4.14	2.21	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3510.52	15.30	43.38	8.90	4.34	3.88	4.57	2.05	3.20	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	3787.46	53.69	21.40	7.33	6.93	3.37	3.76	5.35	2.77	3.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5337.98	10.84	83.27	14.01	7.67	10.31	6.61	3.44	2.64	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	3476.73	8.48	37.18	8.81	4.89	3.91	2.94	1.30	2.28	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	4104.28	94.64	23.88	5.31	8.84	8.40	7.52	3.10	1.77	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	2936.25	30.81	9.61	4.66	5.23	6.08	4.10	1.84	2.97	1.84
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	2393.89	26.11	4.93	5.54	4.43	5.05	3.94	2.22	0.99	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	2586.59	39.49	6.18	5.37	5.37	5.37	3.22	1.34	3.22	2.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	2404.28	25.27	5.70	2.97	5.08	2.60	2.48	2.11	2.23	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	2688.93	32.39	9.69	5.12	6.78	5.54	3.60	1.94	2.35	2.21
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	2510.38	39.44	6.10	5.90	7.12	5.49	4.47	3.66	1.63	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	2612.87	11.18	7.99	3.19	2.05	4.11	1.14	1.14	0.91	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	2402.62	17.44	11.83	5.98	4.86	5.98	4.11	2.12	2.49	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	2628.16	14.21	4.15	2.19	2.62	3.06	2.40	0.87	1.31	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	3045.51	8.57	11.52	5.61	4.73	8.27	6.50	3.84	2.36	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	2453.20	9.06	8.58	4.29	4.77	3.81	2.38	3.66	1.75	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	2474.60	8.94	5.36	2.68	3.13	2.23	3.57	1.34	0.67	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	2563.37	7.06	10.89	3.83	4.64	7.26	6.86	2.02	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	2187.36	11.87	8.31	3.56	3.22	4.92	3.73	0.68	2.21	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	2155.71	17.29	2.93	2.48	2.57	1.42	1.33	0.80	1.51	1.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2632.72	6.66	3.12	2.91	2.08	0.83	0.94	0.31	1.14	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2765.04	7.68	1.88	2.56	2.90	0.68	1.54	0.68	0.85	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	2485.39	8.19	4.32	3.65	2.88	2.88	2.43	1.88	1.33	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	2185.15	13.56	2.33	2.00	1.91	1.50	1.41	0.58	0.25	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	2218.63	14.29	3.06	2.65	2.04	2.25	1.63	0.41	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	2926.65	5.78	10.73	2.68	4.33	5.78	3.09	2.06	3.09	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	2596.41	5.65	5.76	3.11	3.46	4.04	2.19	2.19	1.50	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	2176.45	8.84	5.17	3.67	2.33	3.17	3.00	1.50	2.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	2727.61	5.95	9.26	2.87	3.53	4.41	2.42	0.88	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	3015.40	5.78	11.56	5.17	5.66	6.40	5.41	3.07	2.46	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	2401.57	12.16	4.54	2.27	3.08	1.46	3.08	2.76	1.13	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	3203.62	3.21	7.06	1.92	3.85	6.09	7.70	1.28	1.92	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	2145.81	6.73	6.63	3.70	2.94	3.88	2.84	1.33	1.71	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	2450.31	9.65	5.22	3.64	2.37	2.69	2.69	1.11	0.32	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	2399.25	7.30	9.12	3.95	2.43	5.17	4.26	2.13	1.52	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	1947.76	10.45	5.75	3.35	2.40	3.35	3.03	1.15	1.05	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	2498.10	7.25	4.61	3.51	2.63	2.63	1.76	1.76	1.54	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	2320.14	7.01	3.37	3.09	4.21	3.65	3.65	0.56	1.40	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	1280.29	9.72	2.87	2.41	3.61	2.04	1.48	1.20	1.20	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	1856.32	20.59	4.81	4.55	2.94	4.01	3.74	1.60	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	1470.69	27.39	2.60	1.68	1.99	1.84	1.53	0.61	0.77	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	1578.15	18.91	3.63	2.20	2.33	3.11	2.33	1.55	1.55	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	2040.09	5.69	3.80	3.25	2.17	2.17	0.81	1.36	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	1856.97	6.82	3.32	2.21	4.06	3.69	2.40	1.29	0.74	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	2139.18	4.61	4.82	4.39	2.63	3.51	1.97	1.54	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	1562.99	1.98	0.00	1.98	0.00	0.00	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	1672.38	4.22	2.77	1.32	1.58	2.11	1.19	0.92	0.66	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	1855.36	3.63	3.83	4.24	3.03	3.83	2.82	1.21	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	1037.48	1.27	0.51	1.02	0.25	0.00	0.00	0.51	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2378.17	44.59	4.98	5.77	7.37	3.98	3.38	0.60	1.19	2.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	2795.87	27.12	9.71	4.62	4.62	6.32	4.16	2.31	2.31	2.93
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	3388.30	39.89	6.55	5.11	4.71	1.64	3.68	2.66	1.84	2.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3434.41	117.97	5.95	6.57	6.57	6.26	3.44	2.19	3.13	3.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	3412.71	124.61	10.74	10.74	6.22	3.39	1.98	1.41	4.24	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2386.27	67.34	11.53	11.99	7.84	7.38	4.61	4.15	3.23	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	3689.92	71.77	24.75	9.90	2.47	9.90	2.47	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	3145.14	74.65	10.06	8.90	6.96	10.06	6.58	1.93	1.93	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4038.45	86.64	16.04	4.81	14.44	16.04	6.42	3.21	4.81	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3178.58	60.86	13.91	12.17	3.48	6.96	1.74	1.74	8.69	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	2953.07	40.68	13.02	7.49	4.23	5.53	4.88	2.28	3.58	2.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2985.56	45.71	9.06	7.00	7.82	12.35	6.59	3.71	4.53	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3372.25	43.32	13.33	6.66	10.00	10.00	0.00	0.00	3.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	2830.87	15.10	10.91	4.75	3.92	8.11	2.52	1.68	3.92	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	2864.13	32.36	10.46	4.90	2.94	4.90	4.25	1.96	2.29	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3435.88	17.62	9.23	10.07	5.87	5.03	7.55	4.19	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	3105.02	15.90	12.09	5.09	3.82	6.36	4.77	2.54	1.91	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	2946.91	20.72	14.61	4.08	7.47	10.87	5.09	2.38	3.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4481.16	16.71	16.71	6.26	16.71	14.62	6.26	10.44	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	3821.05	14.89	21.19	12.03	14.32	12.60	4.58	4.58	5.73	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	3173.23	11.54	11.25	7.70	7.40	8.88	3.55	2.37	5.03	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3525.51	20.33	15.25	11.86	10.16	5.08	8.47	3.39	8.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	2907.74	24.44	14.08	7.46	6.21	8.70	9.53	4.56	5.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	2800.21	16.57	9.90	4.37	6.44	7.13	3.68	3.22	3.22	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	3666.87	26.34	36.88	5.27	21.07	15.81	5.27	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	2741.63	5.77	9.61	5.38	6.54	9.23	2.69	3.46	5.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	2791.61	12.06	10.11	4.56	6.19	6.19	5.87	1.96	1.96	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	4194.96	11.37	20.73	12.71	9.36	8.03	3.34	2.68	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	3861.93	5.39	18.88	6.93	8.86	13.10	7.32	2.70	3.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	3198.48	16.77	17.46	13.01	4.11	4.79	5.14	1.71	3.08	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4420.44	2.48	7.45	9.94	2.48	4.97	2.48	7.45	7.45	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	4729.83	1.89	24.06	8.02	9.44	21.23	6.13	4.72	1.89	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	3675.28	3.62	22.93	12.07	9.66	12.67	7.85	0.60	5.43	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	5157.46	13.73	24.93	8.65	11.19	8.65	6.61	5.09	3.56	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	4184.62	5.98	17.15	8.77	6.78	10.77	7.98	3.19	4.39	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	4504.34	4.44	22.20	14.80	9.87	13.81	8.39	2.47	5.92	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	4761.90	4.72	36.59	40.13	21.25	33.05	16.53	9.44	12.98	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	4470.95	8.17	21.59	9.34	7.00	14.59	5.83	3.50	5.83	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	4142.61	3.07	18.43	15.36	12.73	8.34	7.46	3.07	4.39	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	3434.86	3.39	15.26	10.17	10.17	11.02	7.63	2.54	5.93	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	2496.30	8.95	5.97	9.55	4.18	4.78	7.16	1.19	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	2715.93	9.70	11.65	8.73	7.28	6.31	6.31	2.43	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	1549.89	14.84	4.57	1.14	1.14	5.71	1.14	2.28	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	1679.07	9.15	2.08	2.49	6.65	6.24	5.82	2.49	2.08	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2383.84	34.86	5.62	4.50	2.25	4.50	1.12	1.12	0.00	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	2501.77	5.71	5.07	3.81	3.17	5.39	1.90	1.27	1.59	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2530.26	13.37	7.10	5.01	2.92	11.28	3.76	2.51	4.18	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	1695.72	46.53	4.29	3.60	4.76	4.41	3.25	1.51	0.58	4.18
Hep-2 cells mock treated, biol_rep2	11899-125E9	1724.48	38.32	4.90	4.56	3.88	3.38	4.39	2.53	1.18	2.53
Hep-2 cells mock treated, biol_rep3	11900-125F1	1633.47	37.08	1.82	3.19	2.50	2.28	2.28	2.28	1.37	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	1761.95	44.16	5.36	4.48	5.90	4.48	6.01	1.86	2.51	3.83
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	1635.05	40.40	3.22	4.08	4.08	2.58	2.58	2.58	0.64	3.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	1643.89	34.01	4.52	3.23	1.94	2.80	1.72	1.72	1.08	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1899.82	41.10	3.99	5.36	4.98	4.61	3.86	2.37	1.49	6.35
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	1706.58	41.00	4.12	5.15	3.95	3.77	3.43	1.89	1.20	2.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1742.83	33.00	2.56	3.84	6.41	3.84	3.52	2.88	1.92	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	1929.02	12.31	3.36	1.12	1.68	0.00	2.24	1.12	1.12	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1998.21	14.71	2.16	2.16	2.16	2.60	3.46	0.00	0.87	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	3050.95	42.30	5.29	5.29	7.93	7.93	10.58	2.64	7.93	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	2176.29	13.05	2.12	3.88	0.71	0.71	0.71	0.35	1.06	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2576.21	9.44	4.36	3.63	4.36	2.18	4.36	0.73	2.91	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	1678.98	27.62	3.32	3.32	2.80	5.94	2.80	1.75	1.22	1.92
Hepatocyte, donor1	11523-119I2	951.53	4.84	3.63	3.63	0.00	0.00	1.21	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	1123.66	4.31	0.00	1.08	2.15	3.23	3.23	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	777.35	2.45	1.84	1.84	1.23	0.61	0.61	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1988.74	41.77	7.83	6.53	5.87	10.44	4.57	3.26	3.26	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	1650.99	10.14	1.40	2.62	2.10	1.22	0.70	0.52	0.35	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	1813.32	22.23	0.55	0.96	1.51	0.96	1.23	0.27	0.82	1.65
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	2760.43	63.68	0.00	3.18	3.18	3.18	3.18	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	2569.99	6.68	0.00	6.68	0.00	6.68	0.00	0.00	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	5091.66	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2443.42	37.38	4.15	4.15	2.77	2.77	4.15	1.38	1.38	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2650.32	30.03	2.50	0.00	2.50	5.01	7.51	0.00	7.51	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	5340.72	83.08	23.74	0.00	11.87	35.60	23.74	11.87	11.87	35.60
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2470.64	35.88	7.69	0.00	2.56	2.56	0.00	5.13	0.00	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	2504.78	59.42	0.00	4.57	4.57	9.14	9.14	0.00	4.57	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	2581.06	55.23	3.25	1.62	0.00	6.50	8.12	4.87	3.25	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	2627.67	45.02	8.34	6.67	5.00	5.00	6.67	3.33	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	2294.52	39.94	7.26	7.26	3.63	0.00	3.63	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2735.61	59.56	3.97	3.97	2.65	11.91	3.97	0.00	5.29	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2639.68	42.13	5.54	3.33	1.11	5.54	7.76	4.43	2.22	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	2765.81	57.62	0.00	10.48	5.24	5.24	5.24	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	2322.94	53.54	5.67	7.56	4.41	7.56	7.56	2.52	4.41	5.67
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	2435.93	46.40	1.55	3.09	1.55	3.09	1.55	1.55	0.00	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	3219.64	14.63	0.00	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	2382.59	55.56	5.81	3.88	7.75	10.34	4.52	3.23	1.29	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	2567.83	38.64	1.61	1.61	3.22	11.27	3.22	1.61	0.00	9.66
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	3799.53	23.90	0.00	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	2442.19	62.75	4.07	3.26	4.89	6.52	8.15	2.44	2.44	9.78
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2519.28	80.60	1.26	3.36	2.94	2.52	3.78	0.42	1.68	6.72
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	2644.53	57.49	0.00	0.00	0.00	0.00	14.37	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	2458.47	57.06	6.43	4.02	9.64	7.23	3.21	2.41	4.82	8.84
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2412.53	36.93	2.77	4.62	2.77	5.54	6.46	3.69	0.00	5.54
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	2367.68	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2203.94	40.12	3.78	5.66	8.02	5.66	8.02	3.78	2.83	8.97
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2272.90	49.88	5.44	5.44	6.35	5.44	2.72	3.63	0.91	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	3228.60	29.48	14.74	14.74	14.74	0.00	14.74	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	2373.92	48.43	3.23	2.15	5.38	10.76	6.46	2.15	3.23	8.61
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2883.95	55.90	2.54	6.35	1.27	1.27	2.54	1.27	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	3088.91	32.86	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2225.50	53.57	1.91	2.55	3.83	4.46	5.10	1.91	2.55	4.46
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	2768.62	49.21	7.29	9.11	14.58	0.00	3.65	7.29	3.65	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	3318.92	15.80	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2544.21	39.27	7.14	4.28	9.28	7.85	5.71	5.00	6.43	7.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	2807.30	33.18	6.64	0.00	3.32	6.64	13.27	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	2543.52	0.00	0.00	0.00	20.85	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	2264.33	42.29	4.32	6.48	4.63	6.79	3.09	1.23	2.78	4.01
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	2839.49	63.22	0.00	1.76	1.76	1.76	3.51	0.00	0.00	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	2649.65	53.43	6.29	9.43	6.29	6.29	6.29	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2289.22	52.15	4.87	4.17	2.78	4.87	4.87	1.39	3.48	7.65
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2972.19	57.54	4.43	4.43	0.00	4.43	6.64	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	2901.60	45.39	0.00	0.00	0.00	3.24	9.73	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	2227.78	50.57	2.62	6.98	6.98	9.59	4.36	4.36	3.49	5.23
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2585.00	62.99	0.00	2.25	4.50	2.25	4.50	0.00	2.25	11.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	2533.29	48.78	3.48	3.48	3.48	6.97	0.00	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2642.40	37.34	6.40	6.40	6.40	5.33	1.07	2.13	5.33	11.73
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2531.20	54.03	0.00	1.39	0.00	6.93	1.39	0.00	0.00	8.31
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2413.61	71.24	2.85	0.00	0.00	2.85	0.00	0.00	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	2153.80	50.62	6.44	1.84	0.92	5.52	5.52	0.92	1.84	9.20
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	2583.62	30.25	12.10	0.00	9.08	3.03	6.05	6.05	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	2607.65	18.63	12.42	6.21	0.00	0.00	6.21	0.00	6.21	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2398.12	23.26	6.34	3.17	5.29	3.17	1.06	3.17	1.06	4.23
Keratinocyte - epidermal, donor1	11272-116H3	2026.84	80.62	3.18	2.53	1.96	2.37	1.88	0.90	0.90	0.57
Keratinocyte - epidermal, donor2	11349-117G8	2171.53	77.30	2.34	2.93	0.59	1.17	0.00	0.00	0.59	2.93
Keratinocyte - epidermal, donor3	11421-118F8	2234.17	38.71	3.88	3.50	2.75	3.50	3.22	1.70	1.51	1.42
Keratinocyte - oral, donor1	11251-116E9	3441.17	20.32	2.61	2.95	3.63	4.20	2.95	0.79	2.16	2.61
Keratocytes, donor1	11527-119I6	2050.95	10.31	0.69	2.06	2.06	1.38	1.03	0.34	0.34	1.38
Keratocytes, donor2	11607-120I5	2024.87	18.75	2.34	0.00	1.17	3.52	1.17	2.34	2.34	1.17
Keratocytes, donor3	11688-122I5	2500.59	5.14	3.36	3.95	2.77	3.36	3.36	0.59	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	160.45	0.00	0.00	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	2004.31	25.89	4.31	3.24	1.08	1.08	3.24	1.08	4.31	2.16
Lens Epithelial Cells, donor2	11609-120I7	2925.86	4.38	0.92	1.38	1.04	0.69	1.15	0.69	0.92	1.04
Lens Epithelial Cells, donor3	11690-122I7	2040.39	16.04	1.01	1.31	0.81	0.81	1.61	0.30	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	2327.43	18.26	2.96	5.22	3.79	2.73	2.25	1.90	1.54	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	1773.80	8.93	3.07	7.26	2.79	3.63	2.23	2.51	1.95	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	1842.98	11.02	4.09	4.41	3.31	3.15	2.36	0.79	1.57	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	1770.16	10.22	5.38	5.91	4.30	3.23	2.15	1.08	2.15	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	1908.33	8.51	6.62	6.62	4.73	3.78	1.26	1.89	4.41	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1811.07	12.18	6.36	3.88	3.77	6.36	2.16	2.26	2.05	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	1651.42	12.72	2.87	1.64	4.10	1.64	1.23	0.82	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2201.30	15.67	3.29	5.81	2.53	5.31	2.28	1.01	1.77	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	1729.12	12.25	3.24	5.77	3.80	3.80	2.53	1.41	1.69	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	1719.78	12.66	4.35	4.35	1.19	2.37	1.58	0.40	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	1903.55	11.63	3.30	2.52	0.97	3.30	1.74	1.16	1.94	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1975.16	9.81	2.59	4.44	3.15	4.81	2.04	1.85	1.48	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	1786.37	12.89	3.48	4.53	3.83	2.79	2.44	1.39	1.74	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	1941.34	14.07	3.82	3.58	2.39	2.62	0.95	0.72	1.43	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1838.13	12.22	5.36	4.26	4.26	3.71	1.79	1.79	1.51	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	1754.13	15.09	3.08	4.00	2.46	2.77	2.46	1.54	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2100.53	9.66	4.36	4.68	1.56	5.30	2.49	1.25	1.87	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	1973.19	12.26	2.01	3.11	1.46	3.29	2.20	0.73	1.83	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	1763.05	11.52	2.30	4.28	3.62	3.29	0.33	0.33	0.99	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2210.01	14.06	4.98	6.15	5.27	3.51	3.81	0.88	3.22	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2213.72	17.92	3.49	5.48	3.73	7.97	2.24	0.25	2.24	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	1761.87	11.15	2.42	3.39	2.91	2.91	2.42	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	2099.97	15.08	2.96	4.04	1.89	3.50	2.69	1.35	1.89	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1872.85	12.72	6.06	3.78	4.54	7.87	2.88	1.51	1.97	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	1802.52	14.00	6.22	4.15	4.15	5.18	1.56	0.52	1.56	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	1913.41	13.82	1.88	2.30	2.72	3.14	2.72	0.84	1.26	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	1835.14	11.13	3.61	4.06	3.46	3.46	1.65	1.35	0.90	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	1984.52	15.13	3.44	7.57	4.13	6.19	1.38	1.38	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	1979.13	11.48	4.33	5.83	2.82	3.39	1.51	0.56	1.69	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1844.07	11.77	3.92	3.39	3.29	5.20	2.76	0.95	2.01	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	1646.11	14.05	0.97	7.27	1.94	1.45	2.42	1.94	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2038.98	16.21	6.28	5.62	2.65	4.30	1.65	0.66	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1889.97	10.53	4.21	4.34	3.35	5.95	3.10	0.99	1.86	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	1767.38	9.63	3.33	2.96	1.48	2.59	2.22	0.37	1.48	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	1941.08	14.08	2.47	3.71	2.72	1.73	1.48	0.74	0.99	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1885.31	12.51	2.89	3.30	3.02	5.77	2.47	0.96	1.24	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	1671.23	12.54	3.54	2.89	1.93	3.54	1.29	0.64	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	2018.31	9.74	5.48	4.56	2.74	2.43	1.52	0.30	1.22	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	1819.42	15.82	2.66	3.22	2.10	4.62	2.10	0.56	1.40	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	1900.12	11.38	3.20	5.69	2.13	1.78	1.78	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2243.54	16.97	5.33	5.33	2.42	3.88	1.45	0.48	3.39	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2132.29	13.07	5.45	4.05	3.42	6.54	2.02	0.62	1.09	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	1820.97	13.25	2.86	4.66	4.30	2.86	2.51	2.51	1.07	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	2057.40	16.01	2.94	2.29	2.29	0.98	1.31	0.98	1.63	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2058.78	16.95	5.41	5.18	4.24	2.83	2.59	1.88	1.41	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	2160.95	21.90	4.70	4.46	1.49	1.98	1.36	0.99	1.98	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2081.55	13.83	4.35	3.84	1.79	3.07	0.77	1.28	1.02	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	1879.65	10.74	3.58	3.28	2.98	6.56	3.58	0.60	0.30	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	3297.04	27.19	2.27	4.53	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	2961.13	21.48	5.37	3.84	6.14	4.60	5.37	4.60	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2938.48	17.07	7.42	2.23	3.71	2.97	2.97	1.48	0.74	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2998.29	22.43	14.39	16.93	13.54	12.69	8.04	6.77	8.04	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2970.84	18.99	4.92	5.63	7.74	2.11	5.63	2.11	1.41	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3166.14	24.28	9.34	4.67	6.54	5.60	1.87	2.80	0.93	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	2571.71	19.58	15.97	16.49	18.03	15.97	13.91	9.27	3.09	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	2886.82	17.84	7.14	1.19	9.52	10.71	4.76	1.19	2.38	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2994.34	20.36	2.94	5.65	4.98	3.62	2.26	1.36	0.45	3.17
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	2885.59	14.25	11.05	8.14	9.60	11.34	7.85	7.27	4.94	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	2762.72	12.60	5.85	4.95	8.10	6.30	5.85	4.50	3.15	4.50
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	3069.57	23.71	3.66	5.69	5.15	4.06	4.20	1.76	2.03	2.30
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	2955.84	22.08	9.24	8.22	11.30	13.87	9.24	5.14	2.57	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	2699.34	12.00	7.06	7.06	6.35	4.94	5.29	2.12	3.53	2.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2809.81	13.99	1.33	3.33	3.33	4.00	1.33	2.67	2.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	3056.82	17.32	14.26	12.73	8.66	13.24	7.13	7.13	4.58	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	2866.56	14.94	7.47	5.60	9.61	6.94	4.00	3.74	1.87	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	3051.08	17.19	8.88	7.75	13.79	10.58	9.64	4.91	5.67	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	3266.61	22.09	7.98	10.43	16.57	9.82	5.52	3.68	5.52	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	3331.00	19.57	4.08	6.52	7.34	8.15	13.05	8.97	4.08	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	2815.87	14.37	7.08	9.16	11.25	9.37	7.29	3.12	3.33	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	2804.57	17.38	11.49	15.69	12.33	9.81	7.57	6.45	3.64	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	3052.90	18.55	1.03	7.21	6.18	8.24	7.21	3.09	1.03	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	2849.91	18.58	13.06	10.74	13.64	12.48	11.61	6.97	5.23	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	2734.01	24.81	8.97	8.67	9.86	7.77	8.37	3.59	4.48	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	2645.12	12.17	5.53	6.64	10.51	8.30	7.75	7.19	3.87	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	3235.47	24.74	10.60	12.02	12.73	14.14	12.37	7.07	3.89	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	2907.83	22.50	8.85	11.06	16.23	10.69	5.53	5.16	2.95	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	3019.79	19.57	4.61	5.76	5.76	11.51	5.76	8.06	1.15	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	3438.43	19.19	8.44	8.44	7.68	11.51	8.44	8.44	3.84	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	2975.02	19.81	18.68	16.98	19.25	22.65	15.85	13.02	7.36	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	3211.31	17.23	2.46	0.82	5.74	6.56	5.74	3.28	4.92	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	3334.45	16.72	8.59	10.39	12.65	16.27	13.56	7.23	5.42	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	3218.00	25.85	7.18	10.05	13.64	14.36	10.05	7.18	5.03	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	3216.92	18.67	2.24	3.73	2.99	4.48	3.73	1.49	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	3118.04	15.61	10.03	9.66	14.86	15.24	15.98	6.32	6.32	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	2781.77	21.11	7.75	7.32	9.91	6.03	5.60	4.31	2.58	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	3158.03	24.83	6.85	7.71	8.56	7.71	8.56	6.85	1.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	3262.14	18.99	13.66	8.00	11.99	13.33	14.99	6.66	4.33	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	3142.63	21.12	8.45	5.43	9.05	9.05	7.84	3.02	1.21	4.22
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2940.69	27.02	5.69	8.53	9.24	6.40	10.66	6.40	2.13	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	3081.08	20.62	8.25	6.87	11.00	11.00	8.59	7.56	3.78	2.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	3085.22	35.43	9.12	10.20	15.03	8.05	9.66	10.20	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	3026.76	18.85	6.73	4.71	5.39	2.02	7.41	6.73	3.37	4.71
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	3228.85	27.04	10.00	10.00	9.63	15.19	12.59	5.56	4.82	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3401.57	50.01	6.98	22.10	8.14	5.81	0.00	4.65	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	2910.91	23.27	7.40	2.12	9.52	3.17	3.17	4.23	3.17	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	3198.01	24.81	10.40	12.00	11.20	15.61	7.60	5.60	3.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	3083.40	21.08	5.09	6.54	1.45	10.18	5.81	2.91	0.00	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3535.94	22.23	11.50	5.37	10.73	8.43	9.96	3.07	6.90	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3656.67	28.12	15.78	10.36	15.78	18.74	18.74	5.43	2.96	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	2931.00	24.46	9.41	7.53	6.59	10.35	6.59	4.70	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	3323.65	19.11	4.53	10.06	10.56	14.58	5.53	3.02	2.51	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	3262.07	22.08	9.46	12.17	13.97	12.62	11.72	9.01	4.06	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	2972.35	30.98	12.05	6.88	10.33	17.21	0.00	12.05	8.61	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	3225.17	26.28	10.24	6.68	11.13	9.35	10.24	6.68	5.79	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	3257.25	19.94	12.12	9.78	15.25	9.78	11.34	4.30	3.13	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2850.06	25.07	7.92	11.22	13.19	11.22	5.28	4.62	5.94	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3016.52	22.83	10.90	8.82	7.26	10.90	8.82	4.15	6.23	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	3062.09	14.00	7.88	5.25	13.13	11.38	10.94	4.38	1.75	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	2778.17	26.28	12.30	9.50	9.50	6.71	7.27	2.80	2.80	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	2869.79	20.32	5.30	7.51	12.37	5.74	4.86	7.51	3.53	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	3117.35	16.97	8.10	7.71	13.89	10.80	11.57	5.40	4.24	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	2848.24	20.25	9.62	10.13	9.11	13.67	9.62	3.04	4.56	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	2904.39	15.86	4.33	5.77	8.17	6.73	6.73	4.33	1.92	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	3254.32	20.27	11.53	11.13	16.30	10.34	8.75	3.58	8.35	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	2898.35	18.23	9.11	9.72	7.29	6.68	6.08	9.11	4.86	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1990.03	21.44	10.38	4.84	8.99	4.84	4.84	4.84	4.84	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	3093.13	20.52	10.26	6.84	8.36	16.34	11.78	5.32	2.66	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	3159.96	22.21	12.39	11.88	21.69	11.36	7.23	12.39	6.20	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	2210.01	12.70	6.05	3.63	10.28	6.05	6.05	4.84	1.81	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	3085.66	20.60	9.51	6.02	10.77	13.94	9.82	4.44	4.44	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	3180.94	28.79	6.40	9.06	7.46	9.06	3.73	4.80	3.20	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2392.35	24.14	8.05	9.19	6.90	6.32	5.75	6.32	4.02	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	3489.08	28.80	9.26	12.34	14.91	10.28	15.94	11.83	6.17	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	3435.62	26.17	9.90	9.20	9.20	8.49	6.37	7.78	5.66	3.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2437.92	21.00	10.78	9.65	6.24	10.21	6.24	6.81	4.54	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	3307.40	18.31	9.15	7.90	13.31	10.82	12.06	5.41	8.74	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3406.23	34.45	7.05	8.61	18.01	18.79	14.09	5.48	7.05	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2619.27	19.21	11.69	6.26	8.77	7.10	4.59	2.51	2.92	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	3546.11	27.41	9.29	13.01	12.08	12.55	10.22	6.97	2.79	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	3287.03	24.09	8.70	8.03	8.70	14.05	8.70	5.35	2.01	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	2421.40	21.92	8.02	8.02	11.23	8.55	5.35	4.28	1.60	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	3496.24	23.44	5.66	9.70	20.20	14.95	9.29	6.06	6.06	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	3194.73	26.62	3.67	6.42	11.93	6.42	3.67	3.67	4.59	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2223.66	31.12	8.89	8.00	6.22	8.89	8.00	3.56	5.33	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	3797.61	33.05	8.55	7.98	14.82	10.26	6.27	5.13	1.14	5.13
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3355.95	42.18	8.44	8.44	9.20	8.44	5.37	3.83	3.07	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	2343.01	32.28	6.57	9.30	10.40	8.21	3.28	2.19	1.09	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	3192.08	25.84	4.90	5.35	8.46	8.91	5.79	2.67	4.01	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	3366.16	46.01	6.24	5.98	6.76	3.64	3.64	2.86	1.82	4.68
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2509.86	33.82	6.63	6.63	5.97	5.30	4.64	2.65	1.99	5.97
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4728.84	39.49	18.71	16.63	12.47	2.08	18.71	2.08	4.16	8.31
Macrophage - monocyte derived, donor1	11232-116C8	595.31	0.68	0.68	0.68	0.23	0.46	0.00	0.46	0.68	0.68
Macrophage - monocyte derived, donor2	11313-117C8	491.62	2.20	0.18	0.92	0.55	0.37	0.92	0.00	0.55	0.92
Macrophage - monocyte derived, donor3	11389-118C3	699.06	3.28	1.31	1.31	1.05	0.66	1.05	0.66	0.66	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1727.94	104.08	1.59	2.66	3.19	0.00	2.12	0.53	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	1071.77	30.42	1.27	1.90	0.95	0.95	0.16	0.00	0.48	0.32
Mallassez-derived cells, donor3	11930-125I4	1599.47	57.82	1.53	1.67	0.56	1.25	0.83	0.14	0.83	0.83
Mammary Epithelial Cell, donor1	11273-116H4	2290.50	40.85	1.10	1.69	0.90	1.20	0.90	0.30	0.50	1.40
Mammary Epithelial Cell, donor2	11350-117G9	2174.52	52.12	0.87	1.45	1.45	2.03	0.87	0.58	0.87	1.16
Mammary Epithelial Cell, donor3	11422-118F9	1990.18	36.42	3.74	2.99	1.50	2.99	2.00	1.00	2.49	1.25
Mast cell - stimulated, donor1	11487-119E2	1529.42	4.07	0.68	1.36	0.68	2.03	0.00	0.00	0.00	0.68
Mast cell, donor1	11563-120D6	1596.27	1.95	4.11	1.51	0.87	0.32	0.43	0.54	0.43	0.65
Mast cell, donor2	11565-120D8	1494.19	2.38	8.32	2.38	1.49	0.00	0.59	0.00	0.30	1.19
Mast cell, donor3	11566-120D9	1499.55	0.68	4.05	5.40	1.80	1.35	0.45	0.68	0.45	0.45
Mast cell, donor4	11567-120E1	1480.19	1.24	6.91	2.48	1.06	0.71	0.00	0.18	0.53	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	1097.29	1.44	1.77	1.33	1.11	0.44	0.67	0.89	0.11	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	1800.66	11.09	9.92	4.09	1.17	0.00	0.58	0.58	1.17	1.17
Mast cell, expanded, donor5	11939-126A4	1377.58	1.26	5.85	2.75	2.29	1.03	0.80	0.46	0.46	0.34
Mast cell, expanded, donor8	11941-126A6	1608.40	3.01	7.03	3.51	1.67	2.01	1.51	0.67	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	2321.09	13.13	0.70	2.59	1.39	1.99	0.70	0.20	0.80	0.99
Melanocyte - dark, donor2	11582-120F7	1989.28	14.19	3.11	5.19	2.77	3.81	3.46	1.38	1.73	0.00
Melanocyte - dark, donor3	11663-122F7	1220.99	17.02	0.65	0.72	0.43	0.43	0.43	0.07	0.36	1.30
Melanocyte - light, donor1	11274-116H5	1019.27	11.75	2.82	1.65	0.71	0.24	0.24	0.47	0.71	0.47
Melanocyte - light, donor2	11351-117H1	1471.40	9.55	6.14	3.41	2.05	0.68	1.36	1.36	0.00	1.36
Melanocyte - light, donor3	11423-118G1	1430.05	11.27	5.20	2.60	1.73	1.73	0.00	0.00	3.47	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	1240.24	12.50	2.71	2.60	2.92	2.50	2.92	1.56	1.35	2.29
Melanocyte, donor2 (MC+2)	12739-135I3	1478.91	11.56	4.03	4.57	2.42	2.96	3.77	0.54	1.61	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	1348.38	5.89	2.68	1.87	1.34	2.68	2.41	1.34	0.54	0.27
Meningeal Cells, donor1	11493-119E8	1993.76	31.14	1.74	2.36	1.74	0.50	0.25	0.50	0.62	2.85
Meningeal Cells, donor2	11573-120E7	1883.83	11.00	1.32	1.76	2.64	2.20	2.20	0.44	0.00	3.52
Meningeal Cells, donor3	11654-122E7	2017.98	37.16	0.73	1.79	0.82	1.47	1.39	0.73	0.90	1.63
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1710.08	11.98	3.14	2.00	3.42	1.71	1.43	0.57	0.29	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	1804.53	26.97	1.21	2.21	2.01	1.11	1.01	0.81	0.50	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1980.45	2.63	5.26	2.63	1.31	0.00	0.00	0.00	0.00	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1854.97	23.55	1.31	2.62	6.54	2.62	0.00	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	2459.95	40.19	7.18	7.18	5.02	3.59	3.59	2.15	2.15	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	1571.74	4.87	3.39	1.48	1.06	0.64	0.64	0.21	0.42	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	1479.29	10.56	0.50	3.52	1.01	1.51	2.01	1.51	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	2214.67	25.27	1.32	2.42	0.88	0.44	0.22	0.88	0.66	2.64
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1570.76	30.68	3.65	5.84	2.19	2.19	0.73	0.00	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	2014.11	24.96	2.66	3.27	2.66	2.86	2.86	2.05	2.66	4.09
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2321.52	3.32	4.43	4.02	2.49	1.80	1.25	0.69	0.69	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2216.22	7.81	2.60	3.72	0.74	1.49	0.74	0.00	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	3046.21	5.53	1.58	4.47	2.76	2.37	1.05	0.92	1.58	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3149.00	5.93	2.37	2.37	3.86	2.67	1.19	1.78	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2975.48	4.67	2.34	4.67	2.34	2.34	7.01	4.67	0.00	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	2372.04	19.85	3.84	1.92	2.56	1.92	3.20	3.20	1.92	4.48
Mesenchymal stem cells - adipose, donor0	11217-116B2	1944.84	42.18	1.77	1.42	1.42	1.77	1.42	0.00	1.06	2.84
Mesenchymal stem cells - hepatic, donor0	11218-116B3	2632.20	5.94	2.81	3.75	1.88	0.94	3.13	0.00	1.25	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2056.61	30.48	10.16	1.45	4.35	5.08	1.45	2.90	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	777.49	11.40	0.80	0.53	1.33	0.80	1.33	0.80	0.00	1.59
Mesothelial Cells, donor2	12156-128G5	845.79	24.52	0.50	0.50	0.00	1.00	0.50	0.00	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	817.53	4.41	0.87	1.30	1.88	1.23	0.79	0.65	0.72	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	116.13	1.35	1.35	1.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	643.51	1.72	0.74	1.23	1.72	0.74	0.74	0.49	0.25	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	596.57	2.94	1.47	0.88	0.59	0.29	0.88	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	124.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	634.77	3.41	1.86	0.62	1.55	0.93	0.62	0.93	0.62	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	523.35	3.53	0.00	0.62	0.41	0.21	0.62	0.00	0.21	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	81.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	685.97	1.75	1.50	3.00	1.75	1.25	0.50	0.25	0.75	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	512.96	4.19	0.47	0.93	0.47	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	608.63	1.22	1.63	2.44	0.41	0.41	1.22	0.20	0.61	1.83
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	513.17	2.38	0.00	1.98	1.19	0.00	0.00	0.00	0.40	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	731.84	1.77	2.65	0.00	0.88	0.00	0.88	0.88	0.00	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	684.27	4.18	1.52	0.76	1.14	0.76	0.38	0.76	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	100.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	696.10	2.76	1.06	2.12	1.27	1.27	1.49	1.06	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	203.50	1.84	0.92	0.00	0.00	0.92	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	440.23	1.49	0.60	1.19	1.49	0.60	0.00	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	145.87	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	674.43	2.51	2.51	2.26	2.51	1.25	0.50	0.25	0.75	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	436.36	4.04	0.71	0.24	1.19	0.00	0.24	0.00	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	154.81	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	531.87	3.91	0.69	1.38	0.92	1.61	0.92	0.69	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	492.82	2.31	0.21	0.84	0.42	0.42	0.84	0.21	0.21	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	604.76	2.04	0.61	0.61	0.20	0.20	0.82	0.00	0.61	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	586.76	1.50	1.72	1.29	0.64	1.07	0.86	0.21	0.43	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	379.67	1.78	0.89	0.44	0.22	0.00	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	462.13	3.72	0.88	0.88	0.44	1.53	0.66	0.44	0.88	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	214.44	3.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	102.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	368.55	2.17	0.27	1.36	0.00	1.09	0.00	0.27	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	437.01	2.65	0.29	0.59	0.59	0.29	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	110.12	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	633.85	4.81	0.48	1.92	0.96	0.48	2.88	0.48	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	498.69	3.20	0.40	1.20	0.80	1.20	0.40	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	156.32	0.00	0.00	0.00	0.00	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	630.23	6.01	2.50	1.50	1.00	0.50	1.00	0.00	1.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	1158.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	124.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	492.22	4.82	1.31	3.50	0.44	0.88	1.75	1.31	1.31	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	101.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	169.70	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	522.86	6.20	0.99	0.99	0.50	0.74	0.50	0.99	0.25	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	122.48	0.00	0.70	0.70	0.00	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	148.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	491.28	4.79	1.71	1.03	0.68	1.37	0.68	1.03	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	190.36	3.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	161.92	2.49	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	526.31	7.57	1.40	2.24	1.96	0.28	1.40	0.84	0.28	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	237.74	4.16	0.00	0.00	0.42	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	181.82	0.58	0.58	0.00	0.58	0.00	0.00	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	317.95	5.73	0.90	1.51	0.60	1.21	0.60	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	384.83	9.18	0.42	0.83	0.42	0.42	0.42	0.00	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	328.79	5.54	0.92	3.69	0.00	1.85	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	317.00	3.98	0.57	1.71	0.57	0.57	0.57	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	289.63	4.42	0.14	0.28	0.69	0.28	0.28	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	429.67	5.70	1.30	1.04	1.81	0.26	0.52	0.52	0.26	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	326.88	4.72	0.00	0.86	0.43	0.43	0.43	0.00	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	165.79	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	268.76	2.94	0.53	0.80	0.80	0.80	0.00	0.53	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	427.74	2.69	0.00	0.90	0.90	0.60	0.60	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	270.93	2.40	0.57	0.42	0.42	0.00	0.42	0.14	0.42	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	482.87	8.92	0.64	1.91	1.91	1.59	0.32	0.64	1.27	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	419.93	5.53	0.44	1.11	0.44	0.66	0.88	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	309.05	4.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	429.57	5.11	0.57	0.85	0.28	0.85	0.57	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	486.69	5.16	0.98	0.74	1.23	1.47	1.23	0.49	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	220.26	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	336.66	3.53	0.59	0.00	0.59	0.29	0.29	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	447.77	2.59	0.00	1.15	1.15	0.58	0.58	1.15	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	439.35	1.65	0.00	0.82	0.41	0.41	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	339.77	3.28	0.30	1.49	0.00	0.00	0.30	0.30	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	1194.10	3.77	0.00	7.53	3.77	3.77	3.77	0.00	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1083.61	5.35	1.78	3.56	1.78	3.56	1.78	3.56	5.35	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	978.82	1.64	1.64	2.96	2.63	0.99	1.64	0.66	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	973.06	2.10	4.21	7.36	1.05	2.10	0.00	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	877.93	2.17	0.40	2.57	1.19	1.78	0.59	0.79	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1225.62	1.86	2.79	1.86	1.86	0.00	0.93	0.00	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1142.74	1.13	3.00	3.76	2.63	1.13	1.88	0.38	0.75	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	759.34	2.93	1.07	1.07	2.40	0.53	0.27	0.53	1.07	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	587.33	1.47	0.34	1.36	0.45	0.23	0.34	0.11	0.11	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	1086.67	2.21	1.47	2.21	3.68	1.47	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	767.66	0.73	1.10	2.20	2.20	0.73	0.73	1.10	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	801.13	3.11	6.22	3.11	6.22	0.00	4.67	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	911.75	1.07	0.00	0.00	0.53	0.53	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	1591.93	0.00	3.86	15.46	7.73	3.86	7.73	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1000.85	1.01	2.02	2.02	5.05	3.03	1.01	2.02	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	856.77	3.37	2.11	2.11	0.42	2.11	1.26	0.00	0.42	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	671.44	5.45	1.36	1.36	0.00	1.36	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2089.86	3.81	2.54	2.54	1.27	3.18	0.64	0.64	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1252.82	1.62	2.43	0.81	1.62	0.00	0.00	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	833.76	1.51	0.00	1.51	1.51	3.02	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	256.96	11.42	0.00	0.00	0.00	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	623.13	6.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	228.12	4.75	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	326.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	1528.30	58.81	0.65	2.37	1.08	1.08	0.43	1.72	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	1875.65	3.14	1.57	4.18	3.66	0.52	2.09	1.57	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	1414.41	10.01	1.33	3.34	0.00	1.33	1.33	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	757.53	8.35	0.00	2.50	1.25	1.25	0.00	0.00	0.83	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	2294.63	8.18	2.47	1.90	3.23	2.28	2.85	2.09	1.33	1.90
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	783.56	7.98	0.00	0.00	0.00	1.60	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	996.80	2.04	0.68	1.36	0.68	4.76	0.00	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	358.34	0.00	1.84	1.84	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	1581.64	5.02	3.77	4.60	1.67	1.26	2.09	1.67	0.00	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	2479.42	12.78	1.86	3.02	1.39	1.63	0.93	0.00	0.93	1.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2817.39	6.49	2.16	5.40	1.89	1.08	0.54	0.00	1.08	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	1320.29	5.05	1.05	1.89	1.05	0.42	1.26	1.05	1.26	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	445.39	0.00	0.00	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	1845.45	5.96	4.96	3.47	2.98	5.96	0.99	0.00	0.99	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2244.94	0.81	1.08	3.25	2.98	2.17	3.25	0.81	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2813.35	7.25	4.76	4.99	3.40	1.13	0.68	0.45	1.36	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	2943.19	2.78	1.14	3.27	2.12	1.63	1.14	0.82	0.33	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	1401.54	4.56	3.28	4.37	2.55	3.65	2.92	1.82	1.46	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	1940.34	4.77	1.59	4.77	3.71	1.06	2.65	1.59	3.18	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1465.35	3.00	2.40	3.00	0.00	3.60	1.20	0.00	3.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	2101.32	3.28	3.28	3.28	2.95	2.95	0.98	0.33	1.64	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	2715.17	3.90	0.65	2.60	1.63	1.30	1.30	0.65	0.81	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	1018.25	1.94	2.12	1.94	1.06	1.23	0.53	0.71	0.88	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2069.61	4.92	7.03	5.63	4.92	5.63	2.11	3.52	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	2381.75	0.92	2.76	3.68	2.30	1.38	1.84	1.38	0.92	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	3520.97	6.43	1.93	6.11	3.53	2.25	2.25	0.96	2.89	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2646.67	4.83	3.45	4.14	5.52	5.17	9.31	4.14	3.10	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	530.97	2.53	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	959.75	3.56	1.78	2.23	1.78	0.45	0.22	0.89	0.45	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	1944.64	5.93	2.96	5.93	3.39	1.27	1.69	0.42	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	2361.17	2.37	2.14	2.14	1.90	0.47	2.61	1.19	1.42	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	2762.65	4.29	3.43	5.58	3.86	3.00	1.72	2.58	2.15	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	550.69	0.00	0.00	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	3181.27	2.00	2.00	5.00	4.33	1.33	1.67	1.33	3.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	648.79	2.71	0.45	0.45	0.00	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	1916.94	10.32	2.78	5.95	2.38	1.98	1.98	0.40	1.98	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3200.11	7.43	1.86	5.57	6.50	5.57	0.00	0.93	3.71	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	2651.63	1.14	4.16	3.41	6.05	3.78	4.54	0.38	1.89	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	2161.93	6.19	0.65	3.26	2.93	1.96	1.63	0.65	0.00	2.61
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	2411.64	1.74	0.00	2.18	1.31	0.44	0.44	0.44	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	684.76	5.43	0.45	0.90	2.26	0.45	0.45	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	2535.49	7.94	2.65	2.65	1.76	3.53	0.88	1.76	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	2139.47	3.99	2.66	9.31	7.98	3.99	3.32	1.99	1.99	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2699.97	4.96	1.49	4.46	3.97	4.46	0.50	0.00	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	1460.10	3.06	1.15	2.30	1.53	0.38	0.38	0.00	1.91	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	3213.49	2.12	3.33	4.54	5.75	2.42	2.12	0.91	1.51	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	1148.44	3.76	1.55	1.77	1.33	1.11	0.88	0.44	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1778.17	4.07	3.39	6.10	6.78	2.03	0.68	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	311.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	2136.32	1.22	3.05	4.88	3.05	6.10	0.00	0.00	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	1466.04	3.15	0.63	2.52	1.89	0.00	0.00	0.00	0.94	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4601.84	1.51	1.51	4.84	3.63	3.03	1.82	1.21	2.12	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	2243.67	3.16	1.58	6.33	4.75	5.54	2.37	2.37	3.96	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1453.33	3.40	2.27	5.67	3.40	1.13	5.67	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	399.57	5.06	5.06	0.00	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	1009.48	35.16	2.48	2.24	1.49	0.87	1.12	0.87	0.50	0.99
Myoblast, donor2	11322-117D8	1800.12	17.84	5.75	7.10	5.95	7.10	5.95	4.22	2.49	0.77
Myoblast, donor3	11398-118D3	1291.15	15.98	0.50	2.02	2.02	0.50	0.34	0.17	1.01	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	3551.86	17.95	3.21	4.09	2.77	1.90	1.61	1.75	1.17	1.17
Natural Killer Cells, donor1	11230-116C6	2167.38	3.08	0.31	1.85	0.92	0.62	1.23	0.62	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	2236.04	6.33	5.73	6.03	4.22	7.84	6.94	3.02	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	2073.18	7.91	5.15	3.68	3.31	2.21	2.58	0.74	1.10	0.18
Neural stem cells, donor1	11275-116H6	1652.83	27.58	2.18	1.45	1.45	0.73	0.73	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	1294.03	9.63	0.00	0.00	1.93	0.00	0.00	1.93	1.93	0.00
Neurons, donor1	11494-119E9	2024.32	15.93	5.69	5.69	3.41	10.24	1.14	2.28	1.14	1.14
Neurons, donor2	11574-120E8	1282.67	25.10	0.88	2.64	1.76	1.10	1.54	0.88	0.22	1.10
Neurons, donor3	11655-122E8	2378.53	20.55	8.22	8.22	7.40	13.98	4.93	7.40	4.11	0.82
Neutrophils, donor1	11233-116C9	121.57	0.93	0.00	0.00	0.00	0.00	0.00	0.93	0.00	1.86
Neutrophils, donor2	11314-117C9	147.84	5.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	190.58	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	2994.51	2.61	1.66	2.37	3.21	1.90	1.42	1.07	0.59	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	3235.84	3.58	8.14	4.88	4.56	9.77	3.91	1.63	5.86	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	2536.39	6.62	4.41	6.02	3.61	2.81	1.60	1.20	2.01	1.20
Olfactory epithelial cells, donor1	11933-125I7	2041.24	4.96	3.17	4.68	3.44	2.89	3.44	1.10	2.20	0.28
Olfactory epithelial cells, donor2	11934-125I8	2292.62	14.04	7.82	8.83	6.80	9.84	8.83	5.93	3.18	0.87
Olfactory epithelial cells, donor3	11935-125I9	2105.86	9.76	3.86	4.20	3.52	3.29	2.61	1.82	1.93	0.23
Olfactory epithelial cells, donor4	11936-126A1	2181.11	6.33	2.63	4.29	3.41	3.51	3.51	0.78	1.75	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	1795.83	16.85	1.81	3.01	0.00	0.60	1.20	0.00	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	2023.36	7.44	5.10	4.04	1.28	0.85	0.64	0.43	1.28	1.49
Osteoblast - differentiated, donor2	11353-117H3	2086.18	5.72	30.86	32.01	13.72	3.43	6.86	5.72	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	2914.23	11.79	24.83	9.93	6.21	6.21	3.72	2.48	1.86	0.00
Osteoblast, donor1	11277-116H8	2608.50	33.81	3.13	4.10	2.74	0.98	0.78	1.17	0.59	1.95
Osteoblast, donor2	11354-117H4	1624.46	21.77	0.70	2.11	2.11	0.00	1.40	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	1971.92	16.71	3.55	3.38	2.31	1.78	2.49	0.89	2.31	1.42
Pancreatic stromal cells, donor1	11249-116E7	1858.99	9.35	2.70	2.36	1.18	2.11	2.27	0.42	0.76	1.01
Pericytes, donor1	11491-119E6	2164.69	3.23	2.45	2.67	2.00	1.22	1.11	0.89	0.11	0.67
Pericytes, donor2	11571-120E5	2418.49	2.94	4.07	2.94	4.30	3.40	1.58	2.72	1.58	0.68
Pericytes, donor3	11652-122E5	2696.93	26.65	5.70	5.90	4.27	4.88	2.44	2.24	2.64	2.44
Perineurial Cells, donor1	11499-119F5	2263.36	14.81	1.24	1.81	0.68	0.57	0.90	0.11	0.23	1.47
Perineurial Cells, donor2	11579-120F4	2076.69	15.46	1.56	1.84	1.47	1.20	1.20	0.55	0.18	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	2264.96	3.19	0.96	1.27	1.27	0.32	0.32	0.00	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	1949.35	2.94	9.06	4.65	4.16	9.06	4.90	3.43	1.22	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1975.14	3.11	3.36	2.98	2.98	2.07	2.07	1.16	1.81	0.00
Placental Epithelial Cells, donor1	11278-116H9	1410.60	10.28	2.15	2.15	2.15	0.96	0.96	0.24	0.96	4.07
Placental Epithelial Cells, donor2	11355-117H5	1919.48	9.98	3.33	2.22	0.00	3.33	0.00	1.11	1.11	2.22
Placental Epithelial Cells, donor3	11427-118G5	2472.94	6.09	2.94	4.32	2.75	1.96	4.12	1.96	1.96	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	1073.72	6.01	6.96	3.16	6.96	5.06	6.96	2.85	1.58	1.27
Preadipocyte - breast, donor1	11467-119B9	1285.16	11.63	1.13	2.44	1.50	0.75	0.38	0.56	0.56	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	687.75	8.48	0.13	0.39	0.26	0.26	0.26	0.13	0.65	1.44
Preadipocyte - breast, donor2	11328-117E5	1504.44	10.58	3.38	3.15	6.75	4.50	4.73	3.15	1.13	0.68
Preadipocyte - omental, donor1	11468-119C1	1210.08	12.47	1.60	2.66	2.88	0.43	1.17	0.85	0.64	0.21
Preadipocyte - omental, donor2	11329-117E6	993.84	7.42	3.06	1.75	1.31	0.87	0.87	0.00	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	1034.40	12.75	0.72	1.58	1.72	0.72	0.57	1.15	0.57	0.72
Preadipocyte - perirenal, donor1	11469-119C2	1143.72	7.87	0.00	0.98	0.98	1.97	2.95	0.00	2.95	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	1863.59	58.35	2.76	2.46	0.61	1.23	1.23	0.00	0.61	3.38
Preadipocyte - subcutaneous, donor2	11356-117H6	1817.34	29.93	3.01	1.42	5.84	6.37	5.84	2.66	2.12	2.83
Preadipocyte - subcutaneous, donor3	11428-118G6	2239.58	25.03	6.81	3.75	4.94	4.09	4.09	1.87	2.38	2.04
Preadipocyte - visceral, donor1	11280-116I2	1865.18	34.28	1.30	1.30	1.68	0.37	0.47	0.56	0.19	3.17
Preadipocyte - visceral, donor2	11357-117H7	1687.94	17.95	4.60	1.84	5.06	5.98	4.14	0.46	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	1412.50	25.70	4.81	2.19	4.60	5.02	4.81	1.99	1.88	2.19
Prostate Epithelial Cells (polarized), donor1	11253-116F2	2511.99	18.71	9.50	3.62	3.32	3.77	2.87	1.21	1.21	0.75
Prostate Epithelial Cells, donor2	11331-117E8	1063.27	31.01	2.44	1.90	3.79	2.57	2.30	1.08	0.54	0.27
Prostate Epithelial Cells, donor3	11404-118D9	1726.83	9.74	3.80	2.02	1.78	1.84	1.53	1.65	1.10	1.22
Prostate Stromal Cells, donor1	11254-116F3	1812.27	27.34	1.94	2.16	1.82	1.48	1.48	0.46	1.03	1.48
Prostate Stromal Cells, donor2	11332-117E9	2046.69	22.41	3.77	4.84	5.02	5.56	3.94	1.97	1.79	1.97
Prostate Stromal Cells, donor3	11405-118E1	2032.34	6.88	6.57	3.75	3.96	5.42	4.69	2.40	1.98	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	2461.44	18.25	1.46	1.46	0.73	1.09	0.36	0.36	0.36	2.55
Renal Cortical Epithelial Cells, donor2	11596-120H3	2038.74	20.31	1.73	2.22	1.59	2.01	1.25	0.35	0.97	0.90
Renal Epithelial Cells, donor1	11517-119H5	2126.82	31.45	1.01	2.54	0.51	0.00	0.00	0.00	0.51	4.57
Renal Epithelial Cells, donor2	11597-120H4	1882.86	21.34	0.71	2.13	1.42	3.56	0.00	2.13	0.71	2.85
Renal Epithelial Cells, donor3	11678-122H4	1930.66	13.02	0.95	1.59	1.69	1.48	1.06	0.74	0.42	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1626.56	4.77	3.40	1.36	2.04	4.09	2.04	1.36	0.00	3.40
Renal Glomerular Endothelial Cells, donor2	11594-120H1	1814.74	25.74	3.77	3.37	2.29	3.23	2.96	0.94	1.89	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	1678.40	23.76	3.55	5.33	2.00	2.22	2.89	1.11	1.33	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1750.78	4.66	2.66	5.32	2.00	0.00	3.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	2410.63	26.63	1.54	2.64	1.32	1.10	0.66	1.54	0.66	2.42
Renal Mesangial Cells, donor2	11598-120H5	2513.58	12.54	2.51	2.51	2.51	1.25	3.13	1.25	0.63	1.88
Renal Mesangial Cells, donor3	11679-122H5	2332.75	8.04	3.33	5.27	2.50	3.88	3.05	1.11	1.94	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	2265.49	33.82	1.61	2.15	1.61	0.27	0.54	0.81	0.54	5.64
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1928.82	13.07	3.80	3.37	1.69	3.80	2.53	0.84	2.53	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	2465.16	25.46	4.05	3.66	3.47	3.66	2.89	1.93	2.12	2.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	2280.90	14.26	1.56	2.33	2.33	1.81	1.56	0.78	1.04	2.85
Retinal Pigment Epithelial Cells, donor1	11528-119I7	2894.18	15.35	1.42	4.26	1.42	1.71	0.85	1.14	1.71	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1896.67	20.58	4.12	5.15	2.06	2.06	3.09	0.00	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3489.87	34.88	6.27	3.26	1.76	2.01	2.01	0.50	1.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	1320.45	1.87	2.41	2.41	1.20	1.60	0.27	0.27	0.40	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	1188.23	9.83	1.79	2.68	0.00	1.79	0.00	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	2347.88	10.46	2.20	4.95	2.75	1.10	1.10	0.55	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1226.82	9.28	1.74	0.58	1.74	0.58	0.00	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	1035.65	27.44	0.52	0.65	1.69	0.78	1.04	0.39	0.26	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	1184.71	18.17	1.89	1.79	1.59	2.18	2.48	0.99	0.70	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	1510.69	33.02	1.90	1.90	0.56	1.34	0.67	0.33	0.33	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	1468.42	23.69	1.12	1.86	1.24	2.60	0.74	0.74	0.37	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	1312.18	18.06	2.33	2.91	2.91	3.50	2.45	1.28	1.05	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	1364.60	19.65	4.39	3.70	1.85	6.01	3.70	1.39	0.69	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1255.45	14.92	1.64	1.23	1.37	1.37	1.10	0.55	0.68	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	1272.06	19.97	3.03	3.33	5.75	2.42	2.27	3.03	1.36	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	1317.23	28.49	0.54	0.90	1.08	1.08	1.08	0.18	0.90	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	1374.46	22.52	2.01	0.86	0.57	2.44	1.00	0.57	0.29	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	1349.37	21.03	2.47	1.93	2.58	3.54	2.25	1.50	0.75	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	1343.11	21.91	1.77	3.32	1.99	3.32	1.11	0.44	1.11	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1358.31	15.10	0.76	0.57	1.15	0.96	0.57	0.00	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	1088.80	16.58	1.02	1.68	1.86	1.77	1.86	0.28	0.47	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	1418.32	32.32	0.38	0.94	0.56	0.56	0.75	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	1020.25	12.61	1.46	0.80	1.19	0.80	0.93	0.27	0.66	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	1121.27	15.96	1.17	0.68	1.36	2.82	2.24	0.68	0.78	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	1275.41	22.72	1.72	0.95	0.57	1.91	0.57	0.76	0.19	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	1132.44	15.59	1.39	0.75	0.64	1.82	0.96	0.43	0.96	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	1345.19	20.74	2.80	1.68	5.61	2.52	2.80	2.24	1.40	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	1133.40	20.34	1.88	1.37	0.34	1.37	1.37	0.17	0.68	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	1095.08	19.14	1.82	1.28	0.18	0.91	0.36	0.36	0.73	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	1190.39	20.36	1.23	2.21	2.70	3.07	2.58	0.86	0.86	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	1248.51	21.63	2.42	1.07	2.55	3.22	1.75	0.54	1.07	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	1670.45	25.00	1.65	1.89	0.47	3.07	1.42	0.71	0.47	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	1264.09	21.23	1.59	1.39	3.17	3.77	3.17	1.59	1.39	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	1432.54	22.45	3.04	2.81	3.04	3.74	2.34	1.64	0.47	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	1528.42	21.36	1.45	1.04	1.45	0.83	1.87	0.41	0.83	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	1350.93	24.33	6.64	3.98	4.42	5.31	5.09	3.32	2.65	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	1155.34	21.10	2.30	1.46	1.04	1.67	1.04	0.63	0.84	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	1410.04	23.28	1.48	1.62	1.21	1.08	0.67	0.40	0.81	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	1075.75	17.71	0.85	0.68	0.85	1.53	0.68	0.00	1.02	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	1103.36	23.91	1.16	0.77	2.89	1.54	1.16	0.00	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1541.76	21.84	2.06	1.03	1.72	2.58	1.03	2.06	0.69	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	1002.70	18.24	1.51	0.96	1.37	1.10	0.69	0.27	0.55	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	1087.79	28.24	4.43	2.46	1.97	3.28	2.30	0.82	1.81	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1322.03	17.21	2.05	1.53	1.36	1.19	0.68	0.51	1.02	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	1151.85	18.35	0.59	0.89	0.89	1.33	1.18	0.15	0.59	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	1187.22	15.46	1.33	1.07	1.60	0.80	0.00	0.80	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	1481.25	11.89	1.66	1.52	1.38	0.83	1.52	0.55	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	1445.99	13.10	2.14	0.48	2.38	2.38	1.67	0.48	1.67	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	1362.02	12.90	1.41	1.81	0.81	0.20	0.00	0.60	0.40	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	1362.61	13.94	2.07	1.41	1.79	2.54	1.41	0.94	0.28	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	2363.44	19.56	5.24	3.49	2.45	5.59	5.24	1.40	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	1490.82	6.95	2.12	2.72	0.00	0.91	1.81	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	1306.84	11.87	4.16	1.35	1.35	1.71	2.45	0.86	0.61	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	1612.87	21.98	2.04	2.77	0.73	0.29	0.73	1.02	0.44	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	1963.40	18.86	6.69	6.08	4.87	2.43	1.22	0.61	3.04	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	1463.89	18.08	2.71	2.11	0.90	0.30	0.30	0.30	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	1446.93	17.42	4.52	2.49	2.26	2.49	2.04	1.81	1.58	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	1652.56	11.38	3.00	1.80	2.40	3.00	1.50	0.90	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1209.20	14.29	6.61	3.78	2.01	2.13	1.18	0.59	1.18	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	1466.37	13.87	7.90	10.46	5.76	4.06	3.20	2.13	1.92	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	1370.83	10.82	5.41	6.01	4.21	0.60	0.00	2.40	2.40	1.20
Schwann Cells, donor1	11498-119F4	2457.71	11.10	4.14	3.76	4.14	6.58	2.63	2.07	2.26	3.20
Schwann Cells, donor2	11578-120F3	2061.86	20.41	3.40	0.00	3.40	3.40	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	1834.37	12.71	3.72	4.60	2.19	5.04	3.51	2.19	1.10	1.97
Sebocyte, donor1	11220-116B5	1646.59	43.27	2.19	0.55	2.19	0.55	0.55	0.00	0.00	1.10
Sebocyte, donor2	11301-117B5	1757.80	42.28	1.38	1.38	2.76	0.92	1.84	2.30	0.46	2.30
Sebocyte, donor3	11378-118B1	1970.23	13.19	2.06	4.12	2.27	3.09	3.30	1.24	1.03	1.44
Sertoli Cells, donor1	11255-116F4	1502.53	6.63	1.66	6.63	0.00	0.00	0.00	0.00	0.00	3.31
Sertoli Cells, donor2	11333-117F1	2796.12	11.30	11.30	8.47	5.65	8.47	2.82	8.47	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	4407.51	23.49	6.77	3.08	2.20	2.02	1.94	0.79	1.41	1.50
Skeletal Muscle Cells, donor2	11358-117H8	2833.55	22.41	8.67	2.89	7.23	8.67	5.78	2.17	2.17	0.72
Skeletal Muscle Cells, donor3	11430-118G8	2758.93	38.46	8.36	5.02	7.52	8.36	3.34	1.67	3.34	6.69
Skeletal Muscle Cells, donor4	11451-119A2	1932.57	23.56	6.44	6.91	5.18	5.97	3.77	1.73	1.57	2.51
Skeletal Muscle Cells, donor5	11455-119A6	1999.57	16.35	5.20	5.65	4.46	7.13	5.20	3.27	2.97	2.38
Skeletal Muscle Cells, donor6	11459-119B1	2065.37	29.70	4.62	5.39	4.77	7.39	6.31	1.69	3.54	4.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	2785.49	11.47	3.53	3.91	2.14	2.27	3.53	0.38	1.26	1.51
Skeletal Muscle Satellite Cells, donor2	11321-117D7	2410.30	9.13	4.71	5.85	4.57	6.42	4.28	2.71	2.28	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	2159.50	26.19	2.18	5.75	4.17	4.27	2.28	2.38	1.79	2.38
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	2813.76	13.48	3.71	1.35	1.18	0.84	0.76	0.59	0.59	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2617.85	27.50	10.13	5.07	7.24	5.79	2.90	0.72	5.79	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	1567.80	9.22	6.05	5.64	6.33	5.23	3.30	1.79	1.65	1.38
Skin - palm, donor1	10286-104F7	456.64	0.00	0.00	0.00	0.00	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	1104.96	17.30	5.05	4.32	2.74	2.59	2.16	1.15	1.15	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	621.60	25.35	1.64	2.45	1.64	0.82	0.82	0.82	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	1359.55	24.15	5.45	5.19	3.89	3.38	2.86	0.91	1.69	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	1822.12	41.84	5.28	3.06	2.78	0.97	1.11	0.97	1.39	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	1219.36	23.21	2.67	2.95	1.55	2.81	3.38	0.42	1.41	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	765.43	21.57	0.63	1.06	1.06	0.21	0.21	0.63	0.21	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	1216.97	13.12	2.47	2.32	1.35	1.20	1.05	0.45	1.05	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3411.70	34.25	14.50	7.10	4.94	8.64	6.48	2.78	2.16	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	683.45	14.67	0.67	0.67	0.44	0.44	0.67	0.67	0.22	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	1741.73	28.80	1.18	5.88	1.18	0.00	1.76	0.59	0.59	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	1091.70	19.89	2.21	2.43	2.43	1.10	0.44	0.66	0.66	2.65
Smooth Muscle Cells - Aortic, donor2	11360-117I1	1815.33	72.46	0.39	3.15	2.76	0.39	1.18	0.39	1.58	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	2214.18	33.99	0.77	1.55	0.00	0.77	0.00	0.00	1.55	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	3349.53	6.00	9.01	6.00	8.01	9.01	4.00	4.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	1916.45	47.11	2.79	3.19	2.13	1.33	0.67	0.53	0.67	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	1872.09	15.74	4.65	2.22	5.54	3.55	5.32	1.11	1.55	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1410.25	33.29	3.46	4.10	3.71	3.33	0.64	1.66	1.41	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	1750.70	10.42	1.95	3.26	1.30	0.98	0.33	0.33	0.65	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	1829.25	15.65	1.48	3.54	0.89	2.07	1.18	0.30	1.48	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	1479.88	12.24	1.85	2.99	0.85	2.42	1.99	0.85	1.85	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2231.08	17.89	2.44	2.60	1.14	0.16	0.49	0.98	0.16	3.25
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	2317.65	9.13	1.22	2.13	3.04	2.44	4.26	1.22	1.52	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	2327.12	18.94	2.02	3.28	2.27	0.51	0.25	0.76	1.77	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	673.28	12.24	18.36	12.24	6.12	0.00	0.00	0.00	6.12	110.17
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1662.25	28.61	2.86	6.20	3.81	4.77	5.25	0.95	1.91	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	1668.82	11.21	2.65	2.36	0.74	1.33	1.33	0.74	0.44	1.03
Smooth Muscle Cells - Colonic, donor2	11320-117D6	1900.77	10.76	3.87	5.38	3.66	6.89	7.53	1.94	2.15	2.80
Smooth Muscle Cells - Colonic, donor3	11396-118D1	1950.12	17.53	4.51	6.51	4.30	2.94	3.36	2.62	2.10	1.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	1832.32	73.01	2.63	3.56	1.86	0.46	1.39	0.62	0.77	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1861.49	60.36	5.39	6.47	4.31	2.16	2.16	3.23	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	1334.69	24.81	4.78	2.09	4.18	2.69	1.49	0.30	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2242.99	15.02	2.73	1.37	2.73	0.00	1.71	0.00	1.02	4.78
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	2892.70	4.71	3.06	2.36	2.59	2.28	1.41	0.39	1.26	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1154.86	19.22	5.33	2.11	1.11	1.01	0.70	0.40	0.20	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	973.24	13.20	2.05	1.82	2.28	2.50	2.05	1.37	1.14	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2186.40	22.94	10.26	9.66	5.43	7.85	3.62	0.60	1.21	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	2347.77	58.02	2.12	4.50	3.44	2.38	1.32	1.32	1.06	3.97
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1365.55	14.91	2.26	1.60	0.93	1.46	0.40	0.40	0.53	1.73
Smooth Muscle Cells - Prostate, donor2	11335-117F3	1953.55	15.40	4.13	3.13	4.26	4.63	3.13	2.13	1.88	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2101.34	7.10	1.78	4.06	1.52	1.78	1.01	0.25	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	1932.91	31.81	2.26	2.26	1.06	1.21	1.21	0.45	0.60	1.96
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	1937.68	6.75	1.50	11.25	5.25	2.25	3.00	0.75	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1345.20	11.63	27.14	11.63	3.88	9.05	3.88	1.29	2.58	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	2561.14	26.51	1.86	6.51	4.65	2.79	2.33	0.00	2.33	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	1715.08	35.34	4.54	3.53	2.02	5.05	7.57	1.51	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	1015.71	35.41	3.13	4.07	3.76	3.13	1.88	0.94	1.25	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1838.14	19.47	2.36	2.36	1.47	1.77	1.77	0.29	1.18	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1513.52	18.24	0.42	1.25	0.58	0.33	0.25	0.00	0.25	2.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	2352.61	3.74	4.67	5.14	4.20	2.80	2.34	2.34	1.87	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	1884.32	65.19	1.87	2.16	1.01	1.01	0.86	0.72	0.43	1.44
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	2356.04	39.52	4.84	8.92	4.84	4.08	3.57	1.27	1.78	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2063.67	29.90	6.77	3.76	4.14	4.70	4.32	1.50	1.32	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	2072.83	12.72	0.98	1.12	1.82	0.98	1.12	0.28	0.42	3.77
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	2917.75	12.99	1.26	1.42	1.34	1.01	1.09	0.59	0.25	0.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1993.77	2.38	2.38	4.76	4.76	0.95	1.90	0.95	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	1636.54	50.64	2.45	2.20	1.47	0.73	0.73	0.00	0.49	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	1659.98	12.81	3.76	3.09	2.87	1.33	1.10	1.55	0.66	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	1791.75	19.02	3.51	4.97	3.80	3.51	1.76	1.76	1.17	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	1733.70	1.17	4.47	2.72	1.36	2.14	1.36	0.58	1.17	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	1049.35	9.78	1.85	2.64	3.44	1.06	2.38	1.32	1.85	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1948.26	5.21	8.55	4.46	6.32	2.60	4.84	3.35	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	1465.02	6.83	5.03	3.23	2.52	0.72	2.16	1.08	1.44	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1104.65	29.24	1.99	1.99	2.27	0.85	1.99	1.14	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1431.71	17.72	2.76	2.36	1.97	2.76	1.58	1.97	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	1684.97	5.59	4.06	5.33	6.86	2.03	3.56	2.29	1.52	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	1781.76	1.60	7.19	3.19	1.20	0.80	1.20	2.00	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	2171.12	3.76	8.36	9.61	4.18	2.51	3.76	3.34	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	2036.04	1.38	5.04	3.21	5.50	1.38	2.29	1.83	3.21	1.38
Synoviocyte, donor1	11291-117A4	1511.18	12.62	2.02	0.50	1.85	2.19	1.35	0.17	1.01	1.35
Synoviocyte, donor2	11368-117I9	1750.67	3.52	4.86	5.36	2.85	5.20	3.18	1.84	1.51	0.67
Synoviocyte, donor3	11440-118H9	1773.43	3.35	4.69	1.34	4.02	5.14	5.14	1.34	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	1938.88	28.94	1.43	1.43	0.71	0.00	0.36	0.71	0.00	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	1999.88	9.91	3.96	1.98	3.96	3.96	0.00	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	2152.69	14.59	2.55	2.32	1.62	3.47	2.32	0.23	0.46	2.78
Tracheal Epithelial Cells, donor1	11292-117A5	2074.62	45.52	2.08	2.72	1.94	1.15	0.50	0.57	0.29	2.80
Tracheal Epithelial Cells, donor2	11369-118A1	2219.26	49.09	3.87	1.55	4.64	3.09	2.32	2.71	1.16	2.32
Tracheal Epithelial Cells, donor3	11441-118I1	2117.71	69.86	6.87	2.86	8.02	10.31	4.01	2.86	3.44	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	1327.43	2.21	2.21	1.60	1.48	2.09	1.11	0.62	0.62	0.86
Urethra, donor2	10319-105A4	1053.88	3.60	1.80	7.19	1.80	0.00	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	1684.82	26.30	1.86	2.66	2.66	1.33	0.80	0.27	0.53	0.53
Urothelial Cells, donor2	11600-120H7	1817.36	16.42	2.40	2.00	3.61	3.61	2.00	0.80	1.20	1.60
Urothelial Cells, donor3	11681-122H7	1933.80	8.25	2.75	3.44	2.52	3.21	2.98	1.38	1.60	1.83
Urothelial cells, donor0	11216-116B1	1962.59	4.68	0.22	2.45	1.56	1.34	2.01	0.45	1.11	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	1384.50	3.56	1.78	2.67	0.89	0.89	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1523.97	1.43	1.43	1.43	1.43	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	1306.75	1.37	5.48	1.37	3.42	2.05	3.42	2.74	1.37	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	2033.31	2.07	2.07	1.72	2.07	2.41	1.38	0.69	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	2143.41	1.74	4.07	2.91	2.91	1.16	1.16	0.00	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	1192.22	2.08	0.00	2.08	0.00	2.08	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1198.64	1.84	2.75	3.67	0.00	1.84	2.75	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	1470.68	2.74	2.74	3.65	5.48	3.65	3.65	2.74	3.65	0.00
Wilms' tumor cell line:G-401	10809-111A8	2498.80	34.29	2.71	6.17	3.33	1.48	2.10	1.48	0.99	2.84
Wilms' tumor cell line:HFWT	10597-108E3	1418.62	8.80	0.88	2.64	0.88	2.64	0.88	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1658.31	15.08	2.23	3.07	3.35	1.12	0.84	1.96	1.40	1.68
achilles tendon, donor2	10292-104G4	1155.19	10.33	4.13	0.00	6.20	0.00	0.00	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	2483.02	26.26	2.04	2.55	2.04	0.76	1.53	1.02	0.00	3.06
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	3255.32	36.68	1.86	3.25	2.32	2.09	0.93	0.70	0.46	4.88
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1541.90	17.45	0.95	0.95	0.24	0.83	0.24	0.36	0.00	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2847.67	105.58	2.45	2.99	1.09	1.63	0.82	0.27	1.36	4.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1758.18	20.80	2.53	3.65	1.97	3.37	2.53	2.25	1.41	3.09
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	1151.73	6.56	1.27	1.06	1.90	1.27	1.06	0.42	0.21	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	2116.17	11.71	4.08	4.08	4.08	2.99	1.91	3.27	1.63	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	4857.16	35.25	7.05	9.69	15.86	4.85	4.41	2.64	3.97	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	3449.00	27.36	4.90	7.35	5.31	3.68	2.86	2.45	2.86	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	6098.61	34.95	5.44	19.41	8.15	3.49	1.55	4.27	3.88	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4038.43	82.80	4.23	6.26	7.54	6.07	6.62	4.78	2.58	11.04
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	4076.04	19.50	3.90	11.70	7.80	7.80	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	3159.93	43.92	2.79	6.27	5.58	4.42	3.72	3.49	3.02	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	4128.18	53.07	5.18	8.03	6.73	4.92	3.88	3.11	1.55	4.14
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	3037.88	33.61	5.84	8.77	3.80	3.80	2.05	3.80	1.75	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1549.51	5.11	1.86	0.46	1.39	0.93	1.86	0.93	0.46	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	1592.37	20.97	2.06	6.17	4.11	3.29	0.41	2.88	0.41	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1186.67	10.74	0.31	2.46	1.23	0.31	1.53	0.31	0.61	4.60
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	2569.64	48.22	1.71	4.27	5.12	4.27	0.43	0.43	0.43	6.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2527.04	35.18	2.12	1.82	1.82	0.00	0.00	0.00	0.61	6.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	2815.53	50.55	1.93	2.41	1.20	1.20	0.72	0.96	0.96	5.05
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1520.64	26.73	2.00	2.00	3.12	2.45	1.34	2.23	1.78	3.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1484.62	22.01	2.33	3.34	1.67	1.67	2.33	1.00	1.67	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	373.50	5.57	0.00	3.72	1.86	0.00	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	2077.28	20.34	1.88	5.27	3.01	3.01	1.51	2.26	0.38	3.39
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1576.18	23.12	0.00	2.18	2.18	1.31	1.74	1.31	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	796.65	7.50	1.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	2641.84	8.71	4.00	4.95	2.35	2.35	2.12	1.41	1.18	3.06
adipose tissue, adult, pool1	10010-101C1	1336.04	1.55	2.64	2.48	1.09	1.24	0.62	0.16	0.62	1.09
adipose, donor1	10184-103D4	3610.52	3.52	109.07	15.25	11.73	15.25	9.97	7.04	5.28	1.17
adipose, donor2	10185-103D5	3461.91	0.81	36.09	10.95	6.08	6.08	3.24	2.43	1.22	1.22
adipose, donor3	10186-103D6	3036.02	9.53	32.40	8.99	5.99	4.08	4.08	1.36	0.82	1.91
adipose, donor4	10187-103D7	2496.25	47.67	10.40	9.53	6.07	4.33	6.93	0.87	0.87	6.93
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	2502.71	32.20	2.53	6.47	2.21	0.32	0.47	0.95	0.32	1.74
adrenal gland, adult, pool1	10081-102A9	1305.92	0.00	3.64	0.00	0.00	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	2284.45	11.47	1.73	2.53	1.20	1.20	0.67	0.67	0.40	2.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	3580.15	27.87	5.36	11.08	5.00	5.72	2.86	3.57	2.86	3.93
amniotic membrane cells, donor1	12235-129G3	702.27	3.25	1.16	1.62	0.93	0.93	0.23	0.23	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	1251.66	1.35	2.03	2.03	1.35	1.35	1.01	0.68	0.34	2.03
amniotic membrane cells, donor3	12237-129G5	995.75	1.77	1.47	1.47	2.36	1.77	1.18	0.59	1.18	1.47
amygdala - adult, donor10196	10167-103B5	375.90	1.19	0.00	1.19	1.19	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	572.21	1.62	0.20	0.41	1.01	0.41	0.41	0.00	0.41	0.41
amygdala, newborn, donor10223	10360-105E9	610.68	4.84	0.32	0.00	1.29	0.32	1.61	0.32	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	2515.15	4.33	3.18	1.66	1.02	0.51	0.64	0.76	0.76	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	9883.04	136.12	13.90	16.11	14.12	7.94	8.60	7.06	5.29	13.02
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	3664.72	13.36	2.00	6.01	1.00	2.00	3.67	2.34	1.34	0.33
aorta, adult, pool1	10052-101G7	1398.82	1.18	1.96	2.55	1.57	1.96	0.98	0.59	1.57	0.59
appendix, adult	10189-103D9	1725.96	2.72	3.49	3.10	3.88	2.72	1.94	1.16	1.94	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	4908.30	19.95	4.13	7.22	2.75	3.78	2.41	2.41	1.38	1.03
artery, adult	10190-103E1	1675.26	4.08	5.43	6.79	4.08	4.08	0.00	2.72	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	1959.91	22.45	1.16	3.33	1.59	1.01	0.00	0.43	0.58	0.58
b cell line:RPMI1788	10427-106D4	2810.30	12.19	1.49	1.49	1.49	1.64	0.59	0.45	0.45	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	1317.60	21.92	3.33	3.61	4.72	1.11	1.39	1.94	1.39	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	2082.87	31.75	0.99	1.89	0.69	0.99	0.79	0.30	0.40	2.48
bile duct carcinoma cell line:TFK-1	10496-107C1	1168.30	7.87	1.51	2.85	0.50	1.17	0.84	0.33	0.50	2.01
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	4463.84	20.69	3.91	16.78	10.63	4.47	3.91	5.03	4.47	5.03
bladder, adult, pool1	10011-101C2	1340.74	0.87	1.96	2.17	2.17	1.85	1.09	0.33	0.98	0.11
blood, adult, pool1	10053-101G8	2064.03	4.43	0.00	0.00	0.00	8.86	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	352.81	4.28	0.86	3.43	1.71	0.00	0.00	0.00	1.71	0.86
bone marrow, adult	10192-103E3	1118.86	4.72	4.72	2.02	0.67	2.02	3.37	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	471.53	1.03	1.03	1.03	1.03	0.00	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	409.69	2.23	0.11	0.33	0.33	0.33	0.45	0.56	0.22	0.33
brain, fetal, pool1	10085-102B4	2703.46	2.67	2.67	5.34	0.00	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	2394.81	10.57	2.31	4.29	5.62	5.95	4.63	1.98	5.29	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	1724.55	3.99	0.25	1.00	0.87	0.37	0.50	0.12	0.37	1.25
breast, adult, donor1	10080-102A8	2034.23	0.00	2.53	3.79	1.26	1.26	0.63	1.89	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1686.68	11.05	1.40	1.78	2.03	0.89	1.14	1.14	0.89	4.57
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	2040.24	10.82	2.47	3.40	1.86	0.93	1.24	1.24	1.24	2.47
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6313.30	19.11	10.36	7.37	9.90	10.13	11.28	5.06	4.37	4.37
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	1848.81	17.67	1.69	4.12	3.15	2.91	0.73	1.45	0.97	5.33
carcinoid cell line:NCI-H1770	10703-109H1	2010.91	5.64	2.82	6.11	6.58	1.41	0.00	0.94	0.94	1.41
carcinoid cell line:NCI-H727	10735-110B6	1663.13	12.25	1.64	2.30	1.86	0.44	1.09	0.88	0.44	1.09
carcinoid cell line:SK-PN-DW	10719-109I8	4042.96	26.94	6.02	11.09	5.39	6.65	1.27	0.95	1.90	2.85
carcinosarcoma cell line:JHUCS-1	10642-109A3	4497.61	9.58	10.38	7.45	6.92	11.45	9.05	3.73	4.26	1.33
caudate nucleus - adult, donor10196	10177-103C6	518.10	0.00	0.00	0.00	1.15	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	589.83	2.18	0.84	1.34	0.84	1.00	0.67	0.00	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	425.63	1.53	0.00	0.00	0.76	0.00	0.00	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	996.15	8.42	1.83	2.56	1.10	1.83	1.10	1.10	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	699.19	0.00	0.00	11.65	0.00	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	634.55	1.07	1.28	0.43	1.07	0.00	0.21	0.21	0.64	0.43
cerebellum, adult, pool1	10083-102B2	703.34	1.38	1.38	1.38	1.38	2.76	0.69	0.69	1.03	0.69
cerebellum, newborn, donor10223	10357-105E6	1108.43	4.98	2.49	0.00	0.00	0.00	0.83	0.00	1.66	0.83
cerebral meninges, adult	10188-103D8	563.28	1.26	1.26	1.26	0.25	1.76	0.76	0.76	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	928.22	3.65	2.92	1.46	3.65	0.00	1.46	0.73	0.73	2.92
cervical cancer cell line:D98-AH2	10552-107I3	4362.50	26.17	2.16	3.02	1.15	1.58	1.44	1.15	1.15	4.03
cervical cancer cell line:ME-180	10553-107I4	2418.63	8.62	1.33	1.33	0.99	0.50	0.66	0.50	0.17	2.65
cervix, adult, pool1	10013-101C4	1816.12	2.73	3.88	1.99	1.78	1.78	1.26	0.73	1.15	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2047.44	18.81	1.53	2.93	1.39	0.98	1.39	0.70	0.28	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	313.50	2.61	0.00	2.61	0.00	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	5141.05	36.04	20.63	5.72	4.10	4.23	3.60	1.99	1.49	3.48
choriocarcinoma cell line:SCH	10785-110H2	2398.08	15.28	2.71	2.83	1.36	1.23	0.86	1.11	0.99	2.71
choriocarcinoma cell line:T3M-3	10618-108G6	1058.76	7.35	0.24	1.19	0.47	0.24	0.71	0.47	0.24	1.42
chorionic membrane cells, donor1	12238-129G6	864.45	3.99	1.14	1.99	1.14	1.14	1.14	0.28	1.14	0.85
chorionic membrane cells, donor2	12239-129G7	1053.67	5.67	1.99	1.29	1.09	0.89	0.80	0.60	0.60	1.19
chorionic membrane cells, donor3	12240-129G8	1327.00	4.95	6.04	6.04	4.40	2.75	5.49	1.10	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2245.80	83.81	11.11	15.15	6.06	13.13	14.14	8.08	4.04	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	3031.89	28.24	2.88	9.03	4.99	2.69	1.92	2.31	2.11	2.50
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2349.45	16.89	1.27	2.96	2.75	1.90	0.84	1.48	1.69	2.11
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2089.07	22.60	2.57	1.80	1.54	2.31	0.77	0.77	0.51	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2070.24	25.40	2.66	3.39	1.69	1.94	1.21	1.94	0.73	3.87
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1955.88	23.42	2.24	3.05	0.61	3.66	0.61	1.02	1.02	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	2571.77	46.23	2.36	4.12	1.18	2.06	0.88	0.00	1.18	3.24
chronic myelogenous leukemia cell line:KU812	10409-106B4	2818.93	33.36	0.26	1.30	2.87	0.26	0.78	0.52	0.78	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	2345.25	15.31	5.71	6.40	7.09	6.40	8.91	4.34	1.37	0.69
clear cell carcinoma cell line:TEN	10636-108I6	4462.76	24.12	4.51	11.45	9.89	5.03	4.86	2.60	2.60	2.78
colon carcinoma cell line:CACO-2	10513-107D9	2421.83	46.68	1.28	3.29	1.46	0.73	0.73	0.18	0.73	2.93
colon carcinoma cell line:COLO-320	10420-106C6	3353.84	12.16	1.90	3.42	1.52	0.38	1.14	0.38	0.38	3.42
colon, adult, donor1	10082-102B1	2075.41	1.19	3.57	3.57	3.57	5.95	1.19	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	1359.63	1.65	5.52	1.53	0.94	0.94	0.59	0.59	0.71	1.06
colon, fetal, donor1	10070-101I7	2588.75	2.47	7.42	1.85	2.47	1.85	3.71	1.24	0.62	2.47
common myeloid progenitor CMP, donor1	12130-128D6	513.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	10114.83	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2695.77	92.21	2.12	8.07	0.85	0.85	0.42	0.42	1.27	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2338.68	78.94	3.92	4.98	2.72	1.21	0.60	0.60	0.45	3.47
cord blood derived cell line:COBL-a untreated	10449-106F8	2423.56	72.62	1.69	3.53	2.40	1.41	0.99	0.42	0.99	3.81
corpus callosum, adult, pool1	10042-101F6	741.10	1.77	0.33	0.66	0.44	0.44	0.22	0.11	0.22	0.44
cruciate ligament, donor2	10295-104G7	1010.66	4.86	3.24	1.62	2.43	0.00	0.81	0.00	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	1707.85	0.00	4.82	5.62	0.00	1.61	4.01	0.00	1.61	0.00
diencephalon, adult	10193-103E4	436.06	1.68	0.72	0.00	0.96	0.48	0.24	0.00	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4643.43	10.79	10.79	11.25	16.30	15.61	16.07	8.73	8.04	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	2396.17	27.44	0.77	1.28	0.77	1.28	0.77	0.77	0.00	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	3625.27	40.44	5.54	5.30	3.13	0.72	1.69	1.93	1.69	1.44
ductus deferens, adult	10196-103E7	1008.64	0.50	1.50	1.99	1.99	5.48	4.98	0.00	1.00	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	2714.83	1.44	7.20	2.88	4.32	7.20	1.44	1.44	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	2320.24	6.62	9.56	6.62	6.62	10.30	7.36	5.15	4.41	1.47
dura mater, adult, donor1	10041-101F5	1466.67	2.73	0.91	0.91	0.91	0.74	0.74	0.17	0.58	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	2622.90	270.71	13.99	6.00	4.66	2.00	1.78	1.11	2.00	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	3527.89	189.43	6.02	4.59	3.30	2.01	2.15	0.57	0.86	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	2809.30	16.03	0.62	4.93	2.47	2.47	0.62	1.85	1.23	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	4323.01	27.85	12.11	13.02	8.78	8.78	9.08	2.72	3.33	2.12
embryonic pancreas cell line:1C3IKEI	10606-108F3	2968.94	27.48	2.78	2.78	3.09	1.85	1.85	0.00	1.54	2.16
embryonic pancreas cell line:2C6	10603-108E9	2334.03	19.70	3.94	2.63	7.88	1.31	0.00	1.31	3.94	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	1634.41	40.56	1.01	4.02	1.68	1.01	1.01	0.67	0.00	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	2319.45	24.47	1.63	2.36	1.27	1.63	0.72	0.54	0.36	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	2020.13	27.66	4.02	5.63	8.68	8.68	7.40	3.38	3.22	0.48
epidermoid carcinoma cell line:A431	10426-106D3	1360.14	16.45	0.78	1.00	0.78	0.56	0.56	0.33	0.33	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	1086.22	19.91	0.22	0.88	0.00	0.22	0.66	0.33	0.11	2.42
epididymis, adult	10197-103E8	1259.42	2.30	2.30	3.77	1.88	1.88	2.30	1.88	2.09	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	746.90	3.02	0.89	0.71	0.00	0.00	0.35	0.18	0.35	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1844.70	32.25	1.18	2.75	2.36	0.00	1.18	0.39	0.39	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2147.12	43.51	3.15	3.93	4.19	5.50	3.54	2.49	1.57	4.72
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	2145.75	38.78	1.97	2.07	1.77	3.74	1.77	1.57	0.98	3.74
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	2079.72	42.68	2.58	3.47	3.02	4.48	2.80	2.13	1.68	5.49
esophagus, adult, pool1	10015-101C6	1682.92	4.88	3.93	1.91	2.65	1.59	1.38	0.21	1.27	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3356.45	5.13	1.88	2.00	0.88	1.13	0.63	0.25	0.75	1.38
eye - muscle inferior rectus, donor1	10272-104E2	630.20	2.41	0.00	0.00	2.41	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	776.45	4.21	4.21	4.21	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	455.39	0.00	0.00	0.00	1.49	0.00	0.00	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	872.48	2.29	0.00	2.29	1.15	2.29	0.00	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	839.46	4.37	2.91	0.00	2.91	1.46	0.00	2.91	0.00	1.46
eye, fetal, donor1	10054-101G9	1736.42	0.76	2.03	3.31	3.05	2.03	4.07	0.76	1.53	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	2554.36	50.78	2.95	6.03	3.21	2.69	1.28	0.90	1.54	3.08
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	3540.87	88.32	3.80	8.07	6.89	2.61	2.37	1.66	2.61	6.17
frontal lobe, adult, pool1	10040-101F4	393.03	1.03	0.00	0.28	0.00	0.19	0.09	0.00	0.00	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	1450.20	15.31	1.50	1.80	1.50	0.90	1.20	0.30	0.30	2.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1529.73	10.52	0.37	0.82	0.91	0.73	0.46	0.27	0.27	1.28
gall bladder, adult	10198-103E9	1181.09	1.45	3.14	2.17	2.66	1.21	2.41	0.24	0.24	0.97
gamma delta positive T cells, donor1	11937-126A2	3017.12	8.59	5.91	8.59	3.22	5.37	0.00	0.00	2.15	1.61
gamma delta positive T cells, donor2	11938-126A3	2216.30	4.86	1.87	4.48	4.11	3.73	1.49	1.12	2.61	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	2653.51	45.41	10.56	6.97	8.87	10.14	7.39	5.70	1.90	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	4104.28	6.38	3.87	6.38	3.67	2.32	1.93	1.55	2.13	4.06
gastric cancer cell line:AZ521	10549-107H9	2561.14	44.10	0.82	1.64	0.98	0.82	0.66	0.66	0.49	1.64
gastric cancer cell line:GSS	10560-108A2	4949.54	18.30	13.73	3.66	6.41	1.83	1.83	2.75	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	3229.70	30.84	7.77	5.48	5.03	7.31	5.71	1.60	2.74	0.69
giant cell carcinoma cell line:LU65	10487-107B1	3307.28	43.60	2.98	4.02	3.44	1.72	1.61	1.26	1.72	4.02
giant cell carcinoma cell line:Lu99B	10433-106E1	3370.22	7.56	1.68	2.10	0.84	1.40	0.42	0.84	0.56	2.66
glassy cell carcinoma cell line:HOKUG	10688-109F4	896.41	10.48	1.75	2.49	2.00	1.50	0.50	0.50	1.00	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	991.35	11.51	0.74	1.69	0.63	0.11	0.32	0.21	0.42	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	1027.45	8.43	0.84	1.12	0.56	0.14	0.14	0.14	0.28	2.11
glioblastoma cell line:T98G	10485-107A8	2266.52	22.19	1.10	1.77	2.32	0.99	0.55	0.11	0.22	2.87
glioma cell line:GI-1	10413-106B8	2270.97	9.66	2.64	0.59	1.17	0.88	0.29	0.29	0.59	0.88
globus pallidus - adult, donor10196	10175-103C4	629.78	0.73	0.00	0.00	0.73	0.73	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	770.12	1.95	0.49	1.22	0.49	0.98	0.73	0.24	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	477.85	4.11	1.37	2.74	0.00	2.74	0.00	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	777.53	9.59	2.13	2.66	1.07	1.60	1.07	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	386.65	14.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	5518.83	21.86	0.00	0.00	10.93	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	7515.82	20.91	10.45	5.23	5.23	20.91	0.00	10.45	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	1169.26	3.84	1.92	3.20	3.52	3.20	1.28	0.32	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	2347.45	44.99	3.21	1.38	2.75	1.84	1.84	2.75	0.92	3.21
hIPS +CCl2, biol_rep2	14384-156C1	2398.34	47.10	4.57	2.74	1.83	0.46	0.91	4.12	0.46	1.37
hIPS +CCl2, biol_rep3	14385-156C2	2300.05	54.75	5.80	1.93	1.93	1.93	0.64	0.64	1.29	1.93
hIPS, biol_rep1	14380-156B6	3128.98	68.99	5.75	4.31	2.87	1.44	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	1920.43	48.01	4.12	2.06	2.06	0.69	2.06	0.00	2.06	0.00
hIPS, biol_rep3	14382-156B8	648.84	3.31	1.10	1.10	0.00	0.00	0.00	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	3863.62	37.64	4.60	5.46	4.88	4.60	2.87	2.87	2.01	3.16
heart - mitral valve, adult	10205-103F7	704.97	2.39	2.69	2.09	2.09	1.20	0.90	1.20	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	656.83	0.78	0.78	2.09	0.00	0.78	0.52	0.78	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	763.53	1.67	1.67	0.83	0.83	0.00	1.67	0.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	1023.55	4.08	1.63	1.63	2.86	1.63	1.43	0.61	0.00	1.22
heart, adult, diseased, donor1	10051-101G6	848.26	0.43	1.28	4.26	1.70	2.55	1.70	0.85	0.00	0.43
heart, adult, pool1	10016-101C7	636.58	0.46	0.92	2.07	0.92	0.92	0.23	0.23	0.23	0.23
heart, fetal, pool1	10046-101G1	2235.65	1.13	0.82	1.13	0.82	1.03	0.31	0.00	0.41	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	1405.94	1.85	0.62	2.78	0.93	0.93	0.31	0.62	0.62	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	1410.36	5.95	1.19	2.38	2.38	1.19	2.38	2.38	4.76	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	2042.18	50.39	3.31	1.99	2.65	4.09	1.77	0.88	1.88	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	2056.93	63.96	3.52	3.03	3.52	5.70	3.40	1.09	1.94	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	2094.13	63.26	2.02	2.53	3.03	2.32	2.02	0.61	1.01	1.11
hepatoma cell line:Li-7	10484-107A7	1041.65	17.35	2.22	0.56	0.67	0.67	0.67	0.00	0.22	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	3081.14	49.35	1.91	2.31	1.61	1.41	0.70	0.60	0.60	3.02
hippocampus - adult, donor10196	10169-103B7	443.83	0.00	0.95	1.89	0.00	0.00	0.00	0.00	0.00	2.84
hippocampus, adult, donor10252	10153-102I9	611.08	1.43	0.82	0.61	0.20	1.02	1.22	0.00	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	344.08	1.99	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	513.56	5.29	1.41	1.41	1.06	0.35	0.35	0.70	0.00	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4299.87	109.86	41.50	16.48	15.26	17.70	12.21	14.04	9.16	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	3290.32	74.22	15.12	9.23	9.82	9.82	7.27	2.75	4.32	3.53
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	3249.61	83.28	19.55	9.39	7.87	8.12	5.08	6.35	2.79	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	4425.77	10.71	72.74	11.28	6.77	7.33	5.64	1.13	2.26	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4868.06	13.94	145.11	32.28	28.15	25.05	30.73	18.85	10.59	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4288.45	13.67	106.29	14.80	10.25	12.15	8.35	3.42	5.69	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	3210.61	9.05	66.86	8.17	9.34	6.42	6.42	4.67	2.34	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	3383.09	4.95	83.37	16.80	12.49	10.13	6.46	4.52	2.15	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	2883.23	9.59	49.63	7.92	2.92	5.84	1.25	1.67	0.00	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	2322.23	12.08	23.68	6.39	3.32	2.13	0.71	0.47	2.13	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	3219.81	12.05	42.43	17.04	8.68	7.23	7.23	2.89	2.25	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	2381.47	12.79	14.81	10.10	4.04	2.02	0.00	0.00	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3249.40	81.68	20.66	13.14	10.02	7.04	7.98	2.50	2.97	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	3513.24	99.73	32.92	18.18	20.14	23.09	23.58	17.20	10.81	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	4219.76	175.42	40.15	18.33	8.73	13.09	9.60	8.73	4.36	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	4267.43	9.74	75.98	14.70	10.31	9.35	5.73	4.20	3.25	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3963.03	7.85	50.15	10.47	6.54	6.98	4.36	2.62	3.92	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	4106.04	7.00	101.45	14.49	8.00	13.99	9.00	10.49	3.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	2926.47	5.65	67.07	23.93	16.96	9.42	7.54	5.27	4.33	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	3773.25	4.55	64.57	18.64	8.18	10.00	7.28	3.64	5.46	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	3063.45	3.13	59.20	12.22	5.33	3.45	5.95	3.45	4.07	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	2626.55	9.47	37.56	10.61	8.17	5.55	4.90	1.96	2.29	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	2420.31	6.68	51.09	11.32	8.42	7.26	5.52	2.03	2.03	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	2724.98	6.58	45.74	8.37	2.99	8.37	5.08	3.59	2.09	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	3404.84	78.89	21.80	14.23	8.31	9.42	9.98	4.80	5.17	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	3148.40	76.17	16.83	11.13	3.71	4.85	3.42	3.14	2.00	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	3730.74	98.81	27.36	12.66	10.62	11.02	7.35	7.35	4.49	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	3529.26	15.49	59.15	20.77	14.44	12.32	17.25	8.80	5.28	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	3250.71	12.35	57.96	13.94	11.72	8.55	6.02	3.48	4.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3575.46	16.34	69.91	16.04	8.47	8.17	7.26	4.24	3.63	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	2879.34	4.65	38.78	10.86	5.17	4.65	4.65	2.07	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2829.35	9.96	29.89	11.95	9.96	5.31	4.65	1.33	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1844.98	2.57	23.86	10.00	5.64	4.87	2.82	1.80	2.57	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	2582.56	15.34	35.54	18.41	8.44	13.55	10.99	2.56	3.32	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	3163.68	12.12	32.56	16.66	9.09	8.33	4.54	6.06	2.27	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	2598.40	13.44	39.65	7.39	6.39	6.72	4.37	4.03	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	3337.13	77.76	22.70	12.32	7.25	5.55	6.28	3.86	3.38	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	3137.44	100.72	43.67	14.71	8.91	13.82	7.58	6.24	4.01	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	3516.62	81.95	31.71	14.63	10.24	9.27	4.39	7.80	1.95	4.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	3327.26	8.86	70.90	14.67	6.72	9.17	6.42	1.53	3.06	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4528.51	16.27	348.10	71.57	26.03	65.06	48.80	9.76	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	4212.90	12.91	135.02	26.48	8.60	10.59	7.94	5.63	5.96	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	3206.08	7.66	68.96	12.59	8.76	5.47	8.76	2.19	4.38	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	2970.35	5.07	68.40	8.32	2.90	7.60	3.62	2.53	3.26	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	3028.82	6.41	83.63	15.66	7.83	11.03	3.20	3.56	3.20	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3148.15	20.29	63.25	14.32	5.97	8.35	4.77	1.19	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	2546.41	10.83	34.26	7.45	3.66	2.57	3.39	1.22	1.22	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	2110.98	9.97	27.21	7.00	3.50	4.85	5.39	3.50	0.81	0.54
immature langerhans cells, donor1	11904-125F5	1299.84	7.99	0.73	1.21	2.42	0.48	0.48	0.97	0.00	0.48
immature langerhans cells, donor2	11905-125F6	1404.45	6.34	3.96	6.34	3.17	0.79	2.38	3.17	0.79	1.58
insula, adult, pool1	10039-101F3	466.64	0.95	0.09	0.19	0.19	0.28	0.19	0.00	0.19	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	2294.89	18.53	2.60	5.20	1.63	0.98	0.98	0.98	0.98	0.65
kidney, adult, pool1	10017-101C8	1193.72	3.00	1.20	1.70	1.60	1.10	0.80	0.20	0.80	0.30
kidney, fetal, pool1	10045-101F9	2457.01	1.20	1.06	1.49	0.85	1.77	0.42	0.21	0.50	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	3708.31	57.09	2.56	2.13	1.85	0.71	0.99	1.28	0.43	1.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	3704.19	26.96	10.51	12.86	10.92	9.68	10.09	4.98	5.81	1.11
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	1632.41	9.36	1.28	1.28	0.92	0.18	0.55	0.73	0.73	1.65
left atrium, adult, donor1	10079-102A7	1431.87	3.27	3.81	1.63	1.63	2.72	2.72	1.09	1.09	0.54
left ventricle, adult, donor1	10078-102A6	1089.69	0.51	2.53	1.52	2.53	2.02	1.52	0.00	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	2213.50	33.65	1.64	3.28	1.92	3.28	0.27	0.27	1.64	3.28
leiomyoma cell line:10964C	10569-108B2	1578.90	18.68	10.78	5.39	6.11	9.34	7.90	4.31	2.87	0.36
leiomyoma cell line:15242A	10570-108B3	1076.64	23.91	3.80	3.26	4.89	5.43	4.35	2.17	2.17	0.54
leiomyoma cell line:15425	10571-108B4	1391.58	12.87	7.28	5.34	6.80	6.56	6.56	2.91	2.19	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	1092.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	910.68	6.27	2.09	2.09	3.14	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	5028.69	88.07	3.66	4.37	3.54	3.31	1.65	2.60	0.71	1.65
liposarcoma cell line:KMLS-1	10782-110G8	2161.79	10.31	2.66	5.00	1.87	2.03	1.09	2.03	1.09	0.78
liposarcoma cell line:SW 872	10726-110A6	1314.77	12.79	0.85	2.56	1.22	0.61	1.10	0.61	0.61	2.19
liver, adult, pool1	10018-101C9	1266.18	13.29	0.97	2.27	1.46	0.65	0.65	0.16	0.65	1.46
liver, fetal, pool1	10086-102B5	1472.22	3.76	2.82	1.88	5.64	0.94	0.00	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	438.93	2.04	0.58	0.73	0.29	0.00	0.29	0.44	0.00	0.58
locus coeruleus, adult, donor10252	10165-103B3	582.26	2.77	0.55	1.48	1.66	0.74	0.92	0.92	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	628.89	5.36	0.56	3.95	2.82	1.97	1.13	0.85	1.13	0.28
locus coeruleus, newborn, donor10223	10362-105F2	1009.06	17.67	3.36	2.52	2.10	2.10	1.68	0.42	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	2072.05	19.79	0.97	1.52	0.69	0.55	0.55	0.69	0.55	2.63
lung adenocarcinoma cell line:PC-14	10408-106B3	843.83	2.76	0.00	2.07	0.00	0.69	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	2086.78	35.85	2.11	5.54	3.43	2.77	2.77	1.32	3.69	0.79
lung, adult, pool1	10019-101D1	1381.62	1.89	2.95	3.54	1.42	1.42	0.71	0.35	0.95	0.83
lung, fetal, donor1	10068-101I5	1707.59	2.85	1.71	1.71	0.00	0.57	0.57	0.29	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	1672.49	0.00	2.75	4.58	1.83	4.12	0.92	0.46	0.92	1.37
lymph node, adult, donor1	10077-102A5	2521.60	2.37	5.68	4.26	3.31	5.21	5.68	1.89	1.89	0.95
lymphangiectasia cell line:DS-1	10727-110A7	2717.37	6.14	2.19	5.26	4.38	2.85	2.85	2.19	1.53	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	2273.56	16.30	2.87	6.94	3.77	3.02	1.96	1.21	1.36	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2500.91	83.25	3.40	3.40	2.55	0.00	0.00	1.70	0.85	3.40
mature adipocyte, donor1	12231-129F8	851.13	2.22	0.89	1.33	1.78	0.44	0.89	0.00	0.44	0.44
mature adipocyte, donor2	12232-129F9	812.27	1.25	0.42	0.62	1.04	0.83	0.00	0.21	0.83	0.42
mature adipocyte, donor3	12233-129G1	891.12	1.90	0.47	1.19	0.95	0.47	0.71	0.24	0.24	0.47
mature adipocyte, donor4	12234-129G2	1111.30	3.16	0.79	1.58	1.32	0.53	0.53	0.26	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	2439.30	17.87	3.57	1.67	0.24	1.43	0.24	0.00	0.95	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	326.00	1.13	0.00	0.00	1.13	0.00	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	523.95	1.10	0.37	0.37	0.18	0.00	0.37	0.00	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	338.02	0.95	0.32	1.27	0.64	0.32	0.32	0.00	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	684.94	4.69	1.28	0.85	0.85	2.13	0.85	1.71	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	399.10	1.35	1.18	1.35	0.68	1.69	2.53	1.52	1.01	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	530.99	1.27	0.21	0.42	0.00	0.42	0.64	0.21	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	367.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	186.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	627.41	3.95	0.36	0.36	0.00	0.36	0.00	0.00	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	684.67	1.30	0.00	0.65	0.00	0.00	0.00	0.65	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	693.21	1.39	0.77	0.46	0.77	0.62	0.62	0.15	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	546.49	2.53	0.16	0.08	0.24	0.16	0.00	0.00	0.24	0.24
medulla oblongata, newborn, donor10223	10361-105F1	780.81	5.21	1.39	2.08	2.78	1.74	1.39	0.35	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	5992.51	41.18	10.41	7.53	9.52	10.18	9.30	4.87	1.11	3.32
medulloblastoma cell line:ONS-76	10759-110E3	1463.12	23.97	0.61	2.08	0.49	0.73	0.49	0.37	0.98	2.20
melanoma cell line:COLO 679	10514-107E1	1400.09	26.74	4.46	1.72	1.01	0.29	0.72	1.01	0.43	1.29
melanoma cell line:G-361	10465-106H6	1604.62	16.29	5.43	1.36	1.09	0.81	1.09	0.81	0.54	3.26
meningioma cell line:HKBMM	10691-109F7	1787.16	9.77	7.42	8.32	5.61	8.50	8.68	6.33	4.52	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	2196.72	15.86	4.41	7.05	1.76	6.17	3.52	4.41	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	623.43	4.67	1.30	1.56	1.81	1.30	2.07	0.26	0.26	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	1936.19	25.32	2.15	1.07	3.99	4.60	2.61	0.46	1.23	2.30
mesenchymal precursor cell - adipose, donor2	11748-123G2	2058.12	8.00	1.82	3.09	3.82	3.45	2.54	0.73	0.73	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	1714.80	26.92	1.24	0.83	0.83	3.73	0.83	0.00	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	1491.14	5.06	2.25	1.83	2.53	0.84	0.28	1.12	0.70	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	1733.69	6.35	1.16	4.24	2.89	3.66	2.31	1.73	1.35	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	1222.97	4.86	2.08	0.69	3.47	0.69	0.69	0.69	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	2181.47	29.52	5.32	3.78	4.29	5.49	4.81	1.54	1.89	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	1730.87	9.89	3.22	2.65	2.99	3.80	4.83	1.27	1.73	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	1362.45	10.61	2.39	2.25	1.72	2.25	1.99	1.46	0.66	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	1300.44	25.79	2.43	1.89	1.76	2.03	1.76	0.68	0.68	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	1128.29	13.80	0.71	1.14	0.85	1.56	1.42	0.28	0.57	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	2004.12	12.84	3.62	4.28	2.96	1.65	1.98	0.33	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	1420.25	9.55	1.11	1.66	0.97	2.63	2.21	0.42	0.83	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	1270.31	8.73	1.40	1.05	3.84	1.05	2.09	1.05	0.70	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1350.55	4.49	2.45	0.61	1.22	1.43	2.04	0.82	0.41	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	1269.23	8.99	3.59	3.24	2.88	1.08	1.44	0.72	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	1244.91	1.24	1.66	0.93	1.55	0.93	1.76	0.72	0.31	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	673.49	12.31	0.46	1.37	2.05	0.46	1.37	0.91	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1084.14	23.50	0.84	2.52	1.68	1.68	1.68	1.68	1.26	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1294.73	7.17	2.09	1.34	3.14	1.79	1.94	1.49	0.90	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	1522.59	9.54	2.98	1.58	2.28	2.28	2.19	1.49	0.61	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	2134.22	6.26	3.68	7.00	6.26	3.31	2.58	3.68	1.47	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	1089.11	10.30	2.58	2.29	5.44	1.43	2.58	1.14	0.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	1711.84	15.16	8.84	8.00	8.42	5.05	10.53	3.79	3.37	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	1848.14	6.39	5.48	5.48	3.65	3.20	1.83	0.46	1.83	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	1608.63	7.67	4.60	5.37	3.58	1.28	1.79	1.28	1.02	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	1732.83	6.28	5.24	2.62	3.40	3.93	0.52	1.57	1.83	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	1654.73	10.78	5.24	6.16	4.93	3.39	1.85	1.85	2.16	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	1580.17	8.24	7.30	4.24	6.35	4.71	3.77	2.35	1.41	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	1719.70	7.11	5.08	4.06	3.05	3.05	4.74	1.02	1.35	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	1728.68	9.43	1.96	2.75	3.14	2.75	2.36	1.18	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	1582.00	9.27	6.95	4.63	2.78	4.63	3.24	1.39	2.32	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	2415.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	1919.42	6.92	6.63	1.73	2.88	3.75	2.88	1.73	1.44	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	1665.00	5.80	3.79	3.57	2.23	1.78	0.67	0.67	1.56	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	1788.22	7.69	4.57	5.05	4.81	2.88	2.88	2.64	0.96	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	1607.45	9.53	2.93	4.40	4.40	5.13	4.40	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	1693.39	5.71	6.04	5.37	3.69	3.36	3.36	2.35	1.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	1787.35	8.60	6.14	4.91	3.28	2.87	2.05	4.09	1.64	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	1774.93	12.03	7.30	4.30	4.30	3.01	2.15	2.58	3.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2203.93	13.67	5.47	5.47	2.73	10.94	0.00	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	2153.80	5.16	5.16	10.33	0.00	5.16	0.00	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	1977.30	10.07	6.17	8.77	8.12	6.50	2.60	1.30	1.30	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2044.26	8.73	5.82	14.55	7.27	5.82	2.91	1.45	4.36	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	2209.61	6.93	9.06	13.33	10.13	10.13	5.33	6.40	3.20	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	1894.78	6.54	4.91	8.18	10.63	5.72	4.09	3.27	0.82	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	1851.09	8.94	4.66	13.22	11.66	4.66	4.66	4.66	1.94	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2008.48	12.59	4.20	12.59	12.59	4.20	2.10	2.10	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	1959.12	9.93	11.92	6.95	8.94	7.95	3.97	6.95	2.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	2197.69	9.53	4.77	4.77	14.30	9.53	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	1901.64	6.52	4.74	9.49	8.89	2.37	4.15	3.56	4.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2051.88	8.53	10.97	7.31	14.62	4.87	4.87	3.66	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	1704.31	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	2190.24	13.30	2.53	10.77	8.87	10.77	3.17	3.17	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	2152.55	8.62	5.86	10.35	7.59	5.86	2.76	3.79	2.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2035.30	4.30	12.90	10.75	10.75	2.15	6.45	8.60	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	2423.02	3.99	11.98	15.97	11.98	15.97	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	2703.45	13.78	30.99	20.66	6.89	13.78	0.00	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2626.55	6.11	7.74	12.22	7.33	9.78	7.33	3.67	2.04	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	2744.80	5.56	9.53	10.33	7.94	6.36	7.94	1.59	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2877.48	4.72	8.84	12.97	9.43	6.48	8.25	6.48	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2919.42	4.05	9.97	9.66	6.23	4.36	3.74	3.74	3.12	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2987.46	4.01	10.69	8.02	12.03	12.03	5.35	6.68	5.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2500.17	17.74	11.83	15.37	9.46	4.73	4.73	4.73	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	3009.69	17.98	7.70	20.54	17.98	12.84	5.14	7.70	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	2633.80	15.83	4.13	3.44	7.57	2.07	4.82	2.75	2.75	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	2226.63	21.28	8.91	7.42	6.43	3.46	4.95	3.96	2.97	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	1850.49	14.58	10.09	7.85	4.49	1.12	1.12	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	2261.21	25.44	11.45	12.09	7.00	5.09	6.36	5.09	1.27	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1590.17	15.31	5.24	3.63	5.24	3.22	4.03	2.01	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	1921.10	34.89	15.26	8.72	8.72	4.36	6.54	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1566.09	17.74	5.07	21.54	5.07	11.40	6.34	2.53	3.80	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	1488.69	8.50	6.07	1.21	3.03	1.21	1.21	1.21	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	2232.37	18.08	4.52	13.56	13.56	13.56	4.52	4.52	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	1733.85	13.18	7.41	4.12	2.47	7.41	1.65	3.29	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1803.10	6.94	3.77	4.37	1.19	1.39	0.99	1.59	1.19	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1849.29	5.84	9.09	5.52	5.19	3.89	4.87	1.95	0.65	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	1846.77	5.09	9.17	9.17	5.09	3.06	5.09	5.09	4.07	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	313.35	6.19	0.00	0.00	0.00	0.00	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	2600.07	24.81	2.13	3.31	2.36	0.71	0.47	1.18	1.42	3.31
mesothelioma cell line:ACC-MESO-4	10494-107B8	1659.48	14.83	0.23	1.62	0.23	0.70	1.39	0.46	0.23	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	2235.09	76.92	8.55	4.27	4.27	0.00	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	3189.78	144.36	5.24	4.11	3.49	1.85	2.67	0.62	0.92	1.85
mesothelioma cell line:Mero-25	10850-111F4	2176.94	29.50	2.95	4.31	4.77	3.18	2.72	2.95	0.91	6.13
mesothelioma cell line:Mero-41	10851-111F5	2641.07	9.78	4.40	5.87	4.89	3.91	2.69	1.96	1.96	6.11
mesothelioma cell line:Mero-48a	10852-111F6	1987.34	22.36	3.99	5.31	3.54	1.33	1.99	1.55	1.55	1.99
mesothelioma cell line:Mero-82	10853-111F7	3015.95	86.20	9.46	5.78	6.57	2.63	3.15	1.05	2.63	1.84
mesothelioma cell line:Mero-83	10854-111F8	1846.72	44.09	4.77	2.72	3.40	2.55	1.53	1.70	1.70	2.04
mesothelioma cell line:Mero-84	10855-111F9	1856.37	11.37	3.03	2.27	2.78	1.26	2.53	3.79	1.77	2.02
mesothelioma cell line:Mero-95	10856-111G1	1788.64	11.18	3.52	3.31	2.28	2.90	2.69	2.07	1.45	2.07
mesothelioma cell line:NCI-H2052	10847-111F1	1724.06	23.03	2.32	2.98	2.98	1.49	0.99	1.16	0.50	3.31
mesothelioma cell line:NCI-H226	10846-111E9	2091.36	74.21	3.26	5.25	3.26	3.08	1.09	2.17	1.27	2.17
mesothelioma cell line:NCI-H2452	10848-111F2	1816.01	14.69	4.10	2.56	2.05	3.07	1.71	1.20	1.37	2.56
mesothelioma cell line:NCI-H28	10845-111E8	2906.51	19.59	6.11	8.40	4.83	7.38	3.05	4.07	3.82	3.56
mesothelioma cell line:No36	10857-111G2	1472.48	20.22	3.91	1.96	2.28	2.28	1.63	0.00	0.98	1.30
mesothelioma cell line:ONE58	10858-111G3	1657.68	14.09	2.44	5.15	5.42	1.08	1.35	1.90	2.44	0.54
migratory langerhans cells, donor1	11901-125F2	1174.57	0.38	0.77	1.34	2.69	1.15	0.38	1.15	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	830.51	1.34	0.61	1.47	1.10	0.85	0.49	0.85	0.24	0.37
migratory langerhans cells, donor3	11903-125F4	1684.42	0.36	1.08	1.97	1.62	1.08	0.18	0.72	0.00	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	1400.27	11.10	4.90	9.79	6.53	9.47	4.24	3.26	2.61	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	2116.39	38.15	5.93	6.78	6.78	7.63	6.36	3.60	1.91	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	2157.99	28.33	0.46	3.46	2.07	1.15	1.61	0.69	2.53	2.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	2230.41	15.79	4.19	6.47	1.71	2.85	1.52	0.95	1.14	3.81
myelodysplastic syndrome cell line:SKM-1	10772-110F7	4556.42	40.10	2.40	10.16	9.42	4.62	4.25	3.33	2.77	4.44
myeloma cell line:PCM6	10474-106I6	3592.80	26.09	2.17	4.94	2.57	1.78	0.79	1.58	1.58	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	481.93	6.59	0.51	0.00	0.51	0.00	0.51	0.51	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	916.56	4.90	0.78	1.77	0.78	0.20	0.20	0.39	0.00	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	2513.29	23.51	1.45	3.12	1.56	0.89	1.11	0.89	0.78	2.01
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2630.40	23.68	3.24	3.46	1.76	1.18	1.40	0.44	0.59	1.84
nasal epithelial cells, donor2	12227-129F4	2226.73	21.53	0.00	5.52	3.86	0.00	0.00	0.00	0.00	3.86
neuroblastoma cell line:CHP-134	10508-107D4	5988.02	17.48	1.15	4.14	2.53	1.61	0.46	0.69	0.46	1.84
neuroblastoma cell line:NB-1	10539-107G8	2214.16	16.46	0.56	1.12	0.75	0.75	0.56	0.19	0.56	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	1774.84	17.71	1.69	1.69	1.69	1.90	0.84	1.05	0.63	1.27
neuroblastoma cell line:NH-12	10555-107I6	6921.08	12.49	5.59	3.35	3.91	2.42	2.98	1.86	2.05	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	3588.75	7.59	5.46	6.17	4.51	7.12	6.17	3.56	3.80	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	4623.60	7.92	10.93	10.61	9.82	7.60	7.44	6.65	3.96	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	4097.85	12.68	5.23	8.45	5.23	2.62	2.62	1.81	1.81	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	1446.37	10.81	1.27	5.72	1.91	0.00	1.27	0.64	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	1541.10	12.24	3.19	4.26	3.19	1.33	1.06	1.33	1.33	1.60
neutrophil PMN, donor1	12133-128D9	178.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	703.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	1051.24	0.00	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	4567.77	9.13	3.21	3.04	2.20	1.52	1.35	0.68	1.35	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1003.04	4.80	0.80	0.80	0.00	0.80	0.00	0.00	0.80	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	2195.19	6.73	5.13	9.30	6.41	3.21	1.60	2.24	3.85	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	1366.64	6.57	3.94	6.83	5.26	4.47	4.47	3.68	2.63	0.53
nucleus accumbens, adult, pool1	10037-101F1	462.51	1.97	0.37	0.19	0.09	0.37	0.19	0.09	0.09	0.28
occipital cortex - adult, donor10196	10172-103C1	426.50	4.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	608.65	1.34	0.54	1.34	1.34	1.88	0.54	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	658.01	3.28	1.82	0.36	0.73	0.73	1.46	0.36	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	528.47	1.31	1.84	1.84	1.05	0.79	0.79	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	2968.51	1.29	4.29	6.01	4.29	3.00	1.72	3.86	1.72	0.43
occipital pole, adult, pool1	10036-101E9	415.73	2.13	0.08	0.00	0.16	0.00	0.08	0.08	0.00	0.24
olfactory region, adult	10195-103E6	413.63	0.57	0.76	0.38	0.96	0.96	0.38	0.00	0.19	0.00
optic nerve, donor1	10277-104E7	512.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	1659.07	22.10	1.82	0.91	0.80	0.23	0.68	0.34	0.46	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1897.99	11.27	1.79	2.06	1.10	0.55	0.27	0.27	0.27	1.65
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	1944.68	18.29	3.89	3.05	4.91	6.77	7.28	3.73	1.86	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	3274.44	20.21	4.85	2.89	2.54	1.50	1.96	1.27	1.50	2.89
osteoclastoma cell line:Hs 706.T	10704-109H2	1133.24	4.12	0.88	2.65	1.76	0.88	0.59	0.88	0.29	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1138.95	19.62	0.93	0.93	0.93	0.93	0.00	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	2372.09	14.42	1.91	2.12	1.91	0.42	0.42	1.06	1.06	0.64
ovary, adult, pool1	10020-101D2	2653.91	1.75	3.58	2.45	1.92	1.83	1.40	0.44	0.26	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	1106.16	13.38	1.47	2.75	1.65	0.92	0.73	0.55	1.83	0.37
pancreas, adult, donor1	10049-101G4	4314.71	1.88	7.53	9.41	14.11	15.99	6.58	4.70	6.58	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	2798.43	15.93	4.47	8.67	3.63	2.80	1.68	1.12	1.68	5.87
papillary adenocarcinoma cell line:8505C	10437-106E5	2021.07	18.74	5.96	6.30	9.71	7.15	6.64	6.13	2.90	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	948.62	1.82	0.50	0.00	0.83	0.00	0.17	0.33	0.17	0.83
paracentral gyrus, adult, pool1	10035-101E8	401.87	0.64	0.09	0.09	0.00	0.09	0.09	0.09	0.09	0.27
parietal cortex, adult, donor10258	10373-105G4	382.42	1.47	0.73	0.73	0.00	0.00	0.73	0.00	0.00	3.67
parietal lobe - adult, donor10196	10171-103B9	370.55	0.00	0.00	0.00	0.94	0.00	0.00	0.00	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	495.96	1.71	0.29	0.29	1.14	0.29	0.57	0.29	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	403.59	0.79	0.09	0.26	0.18	0.18	0.09	0.00	0.00	0.44
parietal lobe, fetal, donor1	10072-101I9	3444.85	2.91	6.79	8.73	3.88	1.94	2.91	2.91	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	657.25	5.23	0.75	1.12	1.12	1.12	0.00	0.00	0.75	0.37
parotid gland, adult	10199-103F1	2184.84	3.70	1.85	2.47	3.70	3.70	2.47	1.85	1.85	0.62
penis, adult	10200-103F2	1357.82	3.76	2.69	3.76	3.22	5.91	2.15	3.22	2.15	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	3202.56	16.55	5.95	5.21	5.58	6.14	4.65	1.30	1.86	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	1723.28	11.80	2.19	3.50	1.89	1.60	1.46	0.58	0.73	1.02
pineal gland - adult, donor10196	10179-103C8	517.96	2.58	0.00	0.00	0.65	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	594.58	2.96	0.00	2.96	0.00	0.59	0.59	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	381.26	5.02	0.00	0.63	0.63	0.00	0.00	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	1405.39	3.04	4.05	1.01	6.07	1.01	1.01	2.02	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	1470.25	0.52	1.04	1.04	1.56	1.04	0.52	2.08	2.08	1.56
pituitary gland, adult, donor10258	10378-105G9	1361.14	1.70	1.70	2.55	0.00	0.85	2.55	0.85	0.85	0.00
placenta, adult, pool1	10021-101D3	971.18	2.69	1.08	1.61	0.54	0.54	0.86	0.00	0.43	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	2765.73	22.64	5.30	3.58	5.56	4.50	3.44	2.38	2.52	2.78
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	1197.49	2.02	1.71	3.11	1.09	0.93	0.47	0.78	1.25	0.47
pons, adult, pool1	10033-101E6	372.84	2.24	0.09	0.34	0.09	0.43	0.00	0.09	0.09	0.26
postcentral gyrus, adult, pool1	10032-101E5	436.14	1.48	0.17	0.52	0.61	0.26	0.00	0.00	0.17	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	83.66	4.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	4725.90	11.02	5.51	5.51	16.52	0.00	0.00	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	5468.86	23.47	0.00	0.00	0.00	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	1816.26	30.01	1.02	2.48	2.33	1.17	0.44	0.73	1.02	4.81
prostate cancer cell line:PC-3	10439-106E7	1693.95	15.61	1.45	1.45	1.27	0.91	0.54	0.18	0.36	1.45
prostate, adult, pool1	10022-101D4	1533.69	0.45	1.72	1.27	1.00	0.82	1.00	0.27	0.63	0.63
putamen, adult, donor10196	10176-103C5	523.35	2.12	0.71	0.24	0.47	0.94	0.24	0.24	0.24	0.00
putamen, adult, donor10252	10152-102I8	488.22	1.96	5.88	0.00	1.96	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	1202.09	22.95	4.37	0.00	0.00	1.09	0.00	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	373.53	0.97	0.48	0.72	0.24	0.48	1.21	0.00	0.24	0.48
putamen, newborn, donor10223	10365-105F5	1440.85	17.99	0.75	0.75	1.50	2.25	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	1955.96	10.18	0.29	3.78	1.16	1.75	0.58	0.29	0.58	0.87
rectum, fetal, donor1	10067-101I4	3668.05	2.78	4.17	6.95	4.17	6.95	0.00	2.78	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	1339.19	6.78	0.42	1.48	0.85	1.48	1.06	0.85	0.64	2.33
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	1207.84	1.24	0.83	2.07	1.24	0.41	0.83	0.83	0.00	1.24
retina, adult, pool1	10030-101E3	1077.99	1.09	0.70	0.60	0.60	0.40	0.30	0.20	0.70	0.70
retinoblastoma cell line:Y79	10475-106I7	5087.97	37.15	2.34	3.38	6.75	2.34	1.82	1.30	2.08	2.60
rhabdomyosarcoma cell line:KYM-1	10787-110H4	1557.39	21.76	1.72	3.93	1.23	0.86	0.98	0.86	1.35	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	3027.40	10.12	1.41	3.09	1.12	0.84	0.28	0.56	0.84	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	1060.24	4.55	0.76	2.27	1.52	0.00	2.27	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	2753.18	14.89	4.37	3.08	4.05	2.59	2.43	1.78	2.10	2.10
salivary acinar cells, donor2	11772-123I8	3126.60	6.47	13.22	7.16	6.47	6.33	4.54	3.86	2.62	0.41
salivary acinar cells, donor3	11773-123I9	957.99	2.65	0.66	1.99	2.65	1.32	1.32	1.99	2.65	1.32
salivary gland, adult, pool1	10093-102C3	1708.99	2.29	1.14	1.14	1.14	1.14	0.57	0.00	0.00	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	2203.23	24.20	2.78	3.12	1.35	0.67	1.01	0.42	0.67	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	2315.07	27.39	2.94	2.23	1.18	1.18	0.59	0.59	0.47	0.82
seminal vesicle, adult	10201-103F3	977.72	2.65	11.64	13.76	6.88	4.23	3.70	3.17	5.29	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	2133.12	16.52	5.59	6.32	6.80	9.96	6.56	2.92	2.19	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2041.49	3.27	2.77	4.03	6.04	3.27	2.01	2.26	1.01	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	1700.99	10.04	5.02	3.01	2.01	6.02	1.00	2.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	2612.00	10.07	1.48	1.07	1.48	2.28	1.61	0.27	0.54	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	1392.87	14.92	0.77	2.10	1.44	0.22	0.55	0.22	0.33	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	2018.73	25.29	1.42	2.58	1.03	1.55	0.52	0.26	0.52	2.06
skeletal muscle - soleus muscle, donor1	10282-104F3	710.75	0.71	0.00	0.71	1.42	0.71	0.71	1.42	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	1894.29	2.64	2.52	2.64	0.96	1.44	1.08	0.00	1.20	1.32
skeletal muscle, fetal, donor1	10066-101I3	8595.90	5.03	15.08	29.15	15.08	1.01	8.04	11.06	2.01	1.01
skin, adult, donor1	10074-102A2	2951.57	6.79	13.57	0.00	0.00	6.79	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	2860.09	1.89	7.57	12.62	6.31	3.16	3.16	6.31	2.52	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	2119.54	30.35	4.00	7.34	4.67	1.67	2.33	2.33	2.00	3.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1350.65	7.25	2.21	3.78	1.26	4.10	2.52	2.21	1.26	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	2675.72	12.91	6.75	5.59	5.98	4.43	5.20	2.31	3.08	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	4368.58	52.91	1.98	3.63	2.47	1.48	0.33	0.66	1.15	4.12
small cell lung carcinoma cell line:NCI-H82	10842-111E5	3494.78	7.88	5.47	4.34	3.38	4.66	2.41	1.61	2.57	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	659.42	8.72	1.09	0.65	0.87	0.22	0.22	0.44	0.22	0.44
small intestine, adult, pool1	10024-101D6	1309.81	1.19	3.11	1.31	0.96	1.07	0.72	0.48	0.24	1.67
small intestine, fetal, donor1	10064-101I1	3011.74	2.70	3.19	5.65	3.19	3.93	4.42	3.44	2.46	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	1137.10	7.18	7.69	6.67	5.13	5.13	2.56	1.03	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	1162.79	0.52	1.81	3.10	2.84	1.81	0.78	1.03	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	1135.07	6.16	1.88	1.61	0.80	0.80	0.27	0.80	1.34	0.00
spinal cord - adult, donor10196	10181-103D1	754.52	1.38	0.92	1.61	2.06	1.15	1.84	0.23	0.46	0.23
spinal cord, adult, donor10252	10159-103A6	704.96	2.37	0.39	1.18	0.79	0.00	0.39	0.00	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	673.12	2.08	0.00	0.00	1.38	0.00	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	1367.86	3.66	1.22	3.66	4.88	1.83	0.61	1.22	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	1090.63	5.97	2.76	1.38	1.84	2.30	0.92	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	1133.60	10.16	1.49	1.05	0.75	0.90	0.60	0.75	0.60	0.90
spleen, adult, pool1	10025-101D7	1500.47	5.51	2.97	1.65	1.21	0.99	0.99	0.55	0.55	0.22
spleen, fetal, pool1	10044-101F8	1856.07	3.81	1.19	1.51	0.87	0.72	0.95	0.00	0.40	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1647.71	7.04	1.14	0.93	1.14	0.52	0.31	0.41	0.21	2.07
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	2142.75	26.58	1.33	2.47	1.33	0.76	0.57	0.57	1.33	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	1204.56	6.99	3.49	1.40	1.75	5.24	2.10	1.05	1.75	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	3166.15	45.74	4.69	5.08	3.13	5.08	4.69	1.17	1.17	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	1794.75	34.78	0.79	1.58	1.35	0.68	0.45	0.45	0.23	3.04
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	3097.38	61.00	4.66	3.81	9.32	6.78	4.66	3.39	1.27	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	1406.71	44.00	1.27	0.85	0.85	0.00	0.42	1.27	0.00	0.42
stomach, fetal, donor1	10062-101H8	1874.29	2.14	1.07	1.07	1.07	2.14	0.00	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	1659.48	4.56	3.42	6.27	8.55	6.84	2.85	2.85	1.71	0.57
substantia nigra - adult, donor10196	10178-103C7	705.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	691.04	1.04	1.25	0.83	1.25	1.25	0.62	0.21	0.62	0.83
substantia nigra, adult, donor10258	10371-105G2	368.80	3.10	0.00	0.00	0.52	0.00	0.00	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	922.79	7.77	2.83	0.00	0.71	0.71	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	602.28	8.25	0.23	1.38	0.92	0.23	0.46	0.23	0.46	0.92
temporal lobe, adult, pool1	10031-101E4	477.17	1.44	0.17	0.34	0.34	0.34	0.25	0.17	0.17	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	3252.21	5.70	5.70	12.82	8.55	7.12	4.27	3.56	3.56	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	2141.87	4.40	6.15	12.31	7.91	5.27	5.27	5.27	3.96	0.44
tenocyte, donor1	11763-123H8	1613.54	5.24	2.79	3.49	4.19	4.89	5.59	3.49	2.79	0.35
tenocyte, donor2	11765-123I1	1611.86	2.29	5.72	3.82	3.82	5.34	6.10	2.29	2.67	0.00
tenocyte, donor3	11768-123I4	1362.94	7.04	4.08	3.34	7.04	4.82	3.71	3.34	1.11	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3204.10	75.97	3.74	4.59	2.38	1.36	2.38	2.04	2.04	3.74
teratocarcinoma cell line:NCR-G1	10798-110I6	3630.03	29.90	6.32	9.71	3.85	3.08	3.70	3.24	1.85	2.77
teratocarcinoma cell line:PA-1	10807-111A6	3113.19	25.42	3.10	5.42	2.48	2.32	1.24	2.17	1.24	2.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	2925.12	56.75	6.73	5.20	3.17	1.65	1.78	1.90	0.76	2.41
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3331.32	13.61	3.03	3.03	2.27	2.65	2.65	1.51	1.13	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2154.75	7.85	3.71	2.07	1.31	2.18	1.31	0.65	1.53	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2663.60	10.42	10.42	7.17	4.89	10.10	8.14	5.86	1.95	1.95
testis, adult, pool1	10026-101D8	1257.01	2.47	3.11	2.68	1.29	1.29	1.40	0.54	0.75	1.18
testis, adult, pool2	10096-102C6	1000.51	2.71	1.35	1.80	1.80	3.16	0.90	0.90	0.90	2.71
thalamus - adult, donor10196	10168-103B6	524.39	1.10	0.00	0.00	0.00	0.00	0.00	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	626.54	0.94	0.63	0.94	0.94	0.78	0.63	0.31	0.31	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	785.21	6.16	0.00	0.00	0.00	0.00	0.00	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	386.36	1.81	1.15	0.49	0.66	0.66	1.32	0.16	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	654.71	8.05	3.45	3.45	0.58	0.00	1.15	0.00	0.58	0.00
throat, adult	10209-103G2	1476.80	3.25	1.75	5.99	8.74	4.99	2.75	3.00	1.50	0.50
throat, fetal, donor1	10061-101H7	2632.66	1.52	1.52	3.35	4.27	3.96	3.66	1.83	1.52	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	3979.60	40.14	3.58	5.37	4.97	3.18	1.99	3.58	0.99	0.99
thymus, adult, pool1	10027-101D9	3055.82	17.80	9.15	3.78	2.98	2.58	2.19	0.30	1.29	1.99
thymus, fetal, pool1	10043-101F7	2386.06	9.66	1.66	2.39	1.25	1.04	0.73	0.52	0.62	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	3072.99	40.15	6.52	3.72	3.59	3.72	3.32	3.59	0.93	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	6284.54	37.86	7.26	9.36	7.68	4.75	4.33	4.05	2.37	6.84
thyroid, adult, pool1	10028-101E1	1901.44	1.96	2.99	1.87	1.31	1.87	1.49	0.28	1.03	1.40
thyroid, fetal, donor1	10060-101H6	1418.51	0.53	2.64	1.58	1.32	1.05	0.79	1.05	0.53	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	831.50	6.16	15.40	3.08	6.16	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	1448.96	10.70	8.84	6.05	6.51	6.05	4.42	4.65	2.09	2.33
tongue, fetal, donor1	10059-101H5	2215.59	1.97	3.15	5.12	2.36	4.34	1.97	2.76	1.97	0.79
tonsil, adult, pool1	10047-101G2	2516.61	7.01	1.00	2.20	1.00	1.00	0.90	0.20	0.50	1.90
trachea, adult, pool1	10029-101E2	1430.00	5.32	1.55	1.64	1.31	1.15	0.41	0.33	0.49	1.47
trachea, fetal, donor1	10058-101H4	2027.34	3.85	5.00	3.46	0.77	4.23	1.92	0.77	5.77	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	1714.69	16.65	2.13	3.54	2.13	2.83	1.06	1.06	0.35	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	2166.65	17.33	1.42	1.32	1.32	1.32	0.71	0.00	0.51	1.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	3712.70	12.69	9.71	4.70	2.66	3.29	2.19	1.25	1.88	3.60
tridermal teratoma cell line:HGRT	10694-109G1	431.87	1.90	1.90	0.00	0.00	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	3456.95	10.24	2.96	3.89	1.61	1.35	0.85	0.85	1.52	1.10
umbilical cord, fetal, donor1	10057-101H3	1258.16	2.09	2.09	4.17	2.09	2.09	6.26	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	1607.83	0.51	2.05	1.19	1.71	0.85	0.51	0.51	0.51	0.34
uterus, fetal, donor1	10055-101H1	2848.88	2.05	5.12	3.58	6.14	5.63	2.56	1.02	3.07	1.02
vagina, adult	10204-103F6	1447.49	0.65	1.94	0.65	1.29	3.88	0.65	0.00	1.29	0.00
vein, adult	10191-103E2	1722.24	2.85	3.51	4.38	4.38	1.97	3.07	1.97	1.53	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	3079.74	15.22	4.81	4.27	3.47	2.14	2.40	1.07	1.87	0.80